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Abstract 
 
 
Title: Functional brain perfusion evaluation with Arterial Spin Labeling at 3 Tesla  
 
Background: The new clinically available arterial spin labelling (ASL) sequences present some 
advantages relatively to the commonly used blood oxygenation level dependent (BOLD) method for 
functional brain studies using magnetic resonance imaging (MRI), namely the fact of being potentially 
quantitative and more reproducible. 
Purpose: The main aim of this work was to evaluate the functional use of a commercial ASL sequence 
implemented on a 3 Tesla MRI system (Siemens, Verio) in the Imaging Department of Hospital da Luz. 
The first aim was to obtain a functional validation of this technique by comparison with the BOLD 
contrast, using a number of different approaches. The second aim was to accomplish perfusion 
quantification, by resolving some important quantification issues. 
Materials and Methods: Fifteen adult volunteers participated in a single functional imaging session 
using three different protocols: one using BOLD and two using ASL. The subjects performed a motor 
finger tapping task and the data analysis was performed using Siemens Neuro3D and FSL (FMRIB’s 
Software Library). The location and variability of the activated areas were analysed in MNI 
(Montereal Neurological Institute) standard space.  
Results: Topographic agreement between the activated regions obtained by BOLD and ASL was 
found. However, the results show that inter-subject variability and distance to the hand motor cortex 
were smaller when measured with ASL as compared with BOLD fMRI. Quantitative studies revealed 
that ASL allows the calculation of cerebral blood flow (CBF), both at baseline and upon functional 
activation.  
Conclusion: The results suggest that the functional imaging protocols using ASL produce comparable 
results to a conventional BOLD protocol, with the additional advantages of reduced inter-subject 
variability, better spatial specificity and quantification possibilities. 
 
Key-words: fMRI (functional magnetic resonance imaging); ASL (arterial spin labeling), BOLD (blood 
oxygen level dependent); CBF (cerebral blood perfusion). 
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Resumo 
 
 
Título: Técnica de Arterial Spin Labeling em equipamento 3 Tesla na avaliação funcional da perfusão 
encefálica 
 
Introdução: As sequências ASL (arterial spin labeling) recentemente disponíveis para a prática clínica, 
apresentam algumas vantagens relativamente ao contraste BOLD (blood oxygen level dependent) 
convencionalmente usado em estudos funcionais do cérebro com ressonância magnética (RM), 
nomeadamente, o facto de potencialmente permitirem a quantificação do fluxo sanguíneo cerebral 
(FSC), e de serem mais reprodutíveis.  
Objectivo: O objectivo principal deste trabalho foi a realização do primeiro estudo funcional de uma 
sequência comercial de ASL da Siemens implementada no Hospital da Luz. Este estudo contém a 
avaliação comparativa da activação cerebral na função motora pelas técnicas BOLD e ASL. Algumas 
abordagens de quantificação do FSC foram também efectuadas.  
Materiais e Métodos: Num equipamento 3 Tesla (Siemens, Verio) 15 voluntários saudáveis foram 
submetidos a um protocolo funcional usando o contraste BOLD e dois protocolos funcionais usando 
ASL, nos quais realizaram a tarefa motora da mão direita. Os dados foram processados no software 
Neuro3D (Siemens) e no FSL (FMRIB’s Software Library). A localização e variabilidade das áreas de 
activação foram analisadas no espaço MNI (Montereal Neurological institute).  
Resultados: Apesar de ter havido uma concordância topográfica entre as áreas de activação 
detectadas pelas duas técnicas, a região de activação detectada pela técnica ASL apresentou uma 
menor variabilidade entre os indivíduos e mostrou-se significativamente mais próxima do córtex 
motor da mão. Estudos quantitativos revelaram que a técnica ASL permite quantificar o FSC em 
estados de repouso e activação.  
Conclusão: No contexto da RM funcional foi demonstrado que a técnica ASL produz resultados 
comparáveis com o convencional contraste BOLD, com as vantagens adicionais de reduzida 
variabilidade entre indivíduos, maior especificidade espacial e de permitir quantificar o FSC.  
 
Palavras-chave: IRMf (imagem de ressonância magnética funcional); ASL (arterial spin labeling); 
BOLD (blood oxygen level dependent); FSC (fluxo sanguíneo cerebral). 
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Chapter 1  
Introduction 
 
 
In research one scientist’s artefact is another scientist’s science. 
Richard B. Buxton 
 
1.1. Objective of the thesis 
 
Cognitive neuroscience has obtained a powerful tool to study human brain function with the 
advent of functional magnetic resonance imaging (fMRI). Most notably, imaging sequences based on 
the blood oxygen level dependent (BOLD) contrast are currently the predominant method used for 
activation studies. However, the complex nature of the BOLD signal complicates the interpretation of 
its changes [1]. Perfusion fMRI, based on arterial spin labelling (ASL) methods, offers a useful 
alternative to BOLD fMRI. The ASL methods can provide quantitative measures of perfusion, or 
regional cerebral blood flow (CBF), without the need for contrast agents. Because it is widely 
accepted that CBF is a physiological correlate of brain activity, ASL methods can be used to measure 
not only baseline perfusion but also its functional changes. Importantly, changes in CBF are believed 
to be more directly linked to neuronal activity than the BOLD signal, so that perfusion fMRI also has 
the potential to offer more accurate measures of the spatial location and magnitude of neural 
function [1, 2]. 
The work presented in this thesis is the first study of the recently commercially available ASL 
sequence from Siemens at the 3 Tesla scanner of Hospital da Luz Imaging Department. It contains not 
only a series of approaches for functional validation of this technique in healthy volunteers, by 
comparison with BOLD contrast, but it also accomplishes some important quantification issues. The 
main objective was to provide the first results and comparative analyses between these two 
alternative and complementary fMRI techniques for clinical applications.  
This thesis comprises the analysis and optimisation of the ASL sequence for functional studies, as 
well as the evaluation of its potential to provide quantitative values of CBF. Also, it presents some of 
the benefits and possible limitations of this technique by giving a small summary of its physical 
principles and assumptions.   
 
1.2. Previous work  
 
Within the last decade, the field of magnetic resonance imaging (MRI) has expanded to include 
studies of tissue function in addition to anatomy. Clinically, the pre-surgical mapping of eloquent 
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tissue can now be performed using fMRI techniques. Although the BOLD effect is most often used in 
brain activation studies, a drawback of this technique is that it only provides indirect information on 
the change in activity between one state and another, and does not provide a quantitative measure 
of cerebral activity. It provides no information, for example, on the resting or chronic perfusion state 
[1]. Moreover, when longitudinal experimental designs are employed in order to investigate 
processes taking place over long periods of time, BOLD information may not be valid. 
There are two classes of MRI techniques that do provide measures of the resting perfusion state 
[2]. The first class is based on the use of an extrinsic tracer, namely intravascular contrast agents that 
alter the magnetic susceptibility of blood. The second is ASL, which uses magnetic labelling of 
inflowing arterial blood as a free-diffusible tracer, to obtain perfusion images. This technique is 
potentially quantitative and allows the extraction of absolute values for CBF. The main advantages of 
ASL over the first class technique, and over the majority of perfusion techniques, are improved 
spatial resolution and complete non-invasiveness requiring no potentially harmful contrasts 
injection. For that reason, it can be repeated without limit, and can be used to study normal 
physiology and its variations with time. It also has the potential to provide quantitative functional 
activation maps, which cannot be accomplished with BOLD fMRI studies [1].  
The main ASL drawbacks are related to its intrinsically low signal-to-noise ratio (SNR) and the 
short life time of the label. The introduction of higher field scanners (like the 3 Tesla scanner) greatly 
benefited this technique, by improving the SNR of perfusion-weighted maps. Furthermore, in the last 
decade a number of improvements of the labelling strategies were introduced, which aimed to solve 
some of the problematic technical issues such as magnetisation transfer effects, and others [3]. 
Both BOLD and ASL methods are able to provide functional information of the brain, but they are 
quite different, and measure different aspects of brain hemodynamics. Previously, a number of fMRI 
studies made comparisons between ASL and BOLD contrast. Most of these studies were performed 
using BOLD acquired simultaneously with the ASL technique. Some of them suggest that perfusion 
changes have greater spatial resolution than BOLD changes during functional activation. Indeed, 
standard BOLD fMRI studies show apparent activation over relatively distant draining veins, which is 
not observed using perfusion contrast, suggesting that ASL may more accurately localise the region 
of neuronal activity [4]. Moreover, between-subject variability has been found to be smaller when 
measured with perfusion fMRI as compared with BOLD fMRI [5, 6], which implies that blood flow 
changes may be more consistent across subjects than changes in BOLD contrast. Another interesting 
result is that, as long as the same procedure and parameters are consistently used, more 
reproducible results have been achieved with ASL than BOLD [6] (see the review paper [7] for further 
comparisons between these two techniques).  
Despite the remarkable progress over the last decade, ASL has not yet overtaken the traditional 
invasive methods of perfusion imaging in the clinics. However, with improved techniques and 
hardware available, in particular, the move toward 3 Tesla high-field scanners in the standard clinical 
environments, this method is now being pushed from the research and development stage headed 
for clinical applications. 
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1.3. Structure of the thesis 
 
This thesis begins by providing some background theory in Chapter 2, describing the basic 
biological and physiological aspects of brain function. Also, some of the most important 
neuroimaging techniques are mentioned, with particular emphasis on those that measure perfusion 
changes. 
In Chapter 3, functional MRI techniques are introduced, including the theoretical background and 
main implementations of ASL. In particular, the perfusion quantification methods, and some of the 
problems and pitfalls involved, are thoroughly discussed. 
The materials and methods used for this study are described in Chapter 4. It includes the 
methodology applied for the acquisition and processing of the images, as well as for the analyses and 
evaluation of the results. The subsequent approaches developed for the statistical analysis are also 
explained in this chapter. 
Chapter 5 shows the experiments and results obtained in this work. The results are discussed in 
this chapter too. Finally, the conclusions drawn from this work are reported in Chapter 6.     
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Chapter 2  
Functional Neuroimaging  
 
The purpose of understanding the functional organisation of the human brain has inspired many 
neuroscientists for well over 100 years [1], but the experimental tools to measure and map brain 
activity have been slow to develop.  
Neuronal activity is too difficult to localise without placing electrodes directly in the brain [1, 2]. 
Electric and magnetic fields measured at the scalp provide information on electric events within the 
brain, which allow the estimation of the location of a few sources of activity. However, precise 
localisation of the metabolic activity that follows neural activity is much more feasible and allows to 
produce a detailed map of the pattern of activation [1]. This is the basis of most of the functional 
neuroimaging techniques used today, including positron emission tomography (PET) and functional 
magnetic resonance imaging (fMRI). In fact, the physiological basis of these methods is the fact that 
brain cell activity is associated with local changes in metabolism [2], namely with glucose and oxygen 
consumption, and consequently also with haemodynamics, namely blood oxygenation, cerebral 
blood flow (CBF) and cerebral blood volume (CBV). Somehow nature performs a functional 
convolution of brain cell activity, 𝑓(𝑥, 𝑡), at a given location 𝑥 and time 𝑡 with the function “𝑔” which 
produces a certain change in metabolism and in haemodynamics [2]. The result is a map of metabolic 
and vascular events,𝑔(𝑓(𝑥, 𝑡)), associated with changes in brain activity (see Figure 2.1).  
So, in order to understand the functional images obtained with these methods, it is important to 
understand the relationship between local brain activity and the physiological parameters which are 
measured, and also the relationship between these physiological parameters and the obtained 
functional image (Figure 2.1). In this chapter these issues are discussed. 
 
 
 
Figure 2.1: Relationship between an ideal map of brain activity and a metabolic and vascular map that generate functional 
images (adapted from [1]). 
 
 
2.1. Brain structure 
 
Since early stages of human history, the brain has been one of the most studied parts of the 
human anatomy. Recent techniques have allowed increasing the knowledge about the brain 
structures and its functioning [8]. 
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The normal adult human brain typically weighs between 1 and 1.5 kg and has an average volume 
of 1600 cm3 [9], but receives 25% of all body blood flow. The basic anatomical brain structure can be 
seen in Figure 2.2 (a).  
 
Figure 2.2: Brain anatomic structure. (a) Representation of temporal, parietal, frontal and occipital lobes. (b) Some of the 
different types of tissues in the brain. 
 
This organ is composed of three main parts: the forebrain, midbrain and hindbrain [9]. The 
cerebellum, that is visible at the back of the brain (Figure 2.2 (a)), together with the pons and the 
medulla, compose the hindbrain. The medulla, pons and midbrain are often referred collectively as 
the brain stem. These structures are almost completely enveloped by the cerebellum and 
telencephalon, with only the medulla visible as it merges with the spinal cord [9]. As for the 
forebrain, it is composed by the cerebrum, thalamus and hypothalamus. The cerebrum is the largest 
part of the human brain and is divided into sections called “lobes” (Figure 2.2 (a)): the frontal, 
parietal, occipital and temporal and insular lobes [9]. 
In the next subsection, a more thorough review of the cerebrum is shown, as this work is mainly 
focused in tissue detection in this particular area of the brain. 
 
2.1.1. Cerebral cortex 
 
The cerebrum is composed of an outer layer of grey matter, internally supported by deep brain 
white matter. It is responsible for the so called “higher functions”, such as thinking and cognition [8]. 
Grey matter consists of cell bodies of neurons, while white matter consists of axons that connect 
neurons. These are often surrounded by a fatty insulating cover called myelin, which gives the white 
matter its distinctive colouration (see Figure 2.2 (b)). The function of this fatty sheath is to insulate 
nerve endings, enable smoothly movements of brain signals and to accelerate the transmission of 
the nerve signals [9]. 
The brain is surrounded by the meninges and the subarachnoid space, which separates the soft 
brain tissues and spinal cord from the hard surrounding bones like skull and vertebrae. This space 
and the cavities located inside the brain, the ventricular system, are filled with cerebrospinal fluid 
(CSF), which is believed to be produced by the choroid plexus [9] (Figure 2.2 (b)). The CSF is very 
similar to blood plasma and is the other supplier of nutrients to the brain.  
These are the main tissue types that are of interest in this study. 
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2.2. Brain functional anatomy: the hand motor cortex 
 
The cortical anatomy of cerebral gyri is complex and presents tremendous intra- and inter-subject 
variability [9]. Therefore, the identification of specific cortical regions based only on morphologic 
features can be challenging. The presence of space-occupying lesions in the brain, such as tumors or 
vascular malformations, can further complicate this procedure by distorting normal anatomy, 
thereby making the identification of specific cortical regions difficult or impossible. 
Previous studies have demonstrated that the motor function is controlled by four major regions in 
the frontal lobe: the primary motor cortex (M1), which lies just anterior to the central sulcus on the 
precentral gyrus, the supplementary motor area (SMA), the premotor area and the cingulate motor 
area which lie just anterior to M1 (shown in Figure 2.3). The motor cortex located on the left side of 
the brain controls movement on the right side of the body [9]. 
 
 
Figure 2.3: Representation of the principal areas of the motor cortex (adapted from [9]). 
 
The cortical representation of motor hand function, which allowed the development of the 
concept of “homunculus”, is known to be located in the superior aspect of the precentral gyrus [10]. 
Even though functional techniques have recently permitted the identification of anatomic regions 
based on the correspondence with regions of activation, the knowledge of pure anatomic landmarks 
of the cerebral cortex remains of fundamental importance in research and everyday clinical practice.  
Yousry et al. [10] described the hand motor cortex (HMC) in dissected brains or computed 
tomography and MR imaging as having the shape of a typical hook on the sagittal plane and a 
structure like an inverted omega (Ω) or epsilon (ε) on the axial plane (see Figure 2.4). They also 
localized blood oxygen level dependent (BOLD) activation, obtained during hand movement exactly 
on the omega region of the precentral gyrus.  
In summary, the most reliable landmark for the identification of HMC is the inverted omega or 
horizontal epsilon shape of the precentral gyrus in axial scans, or the shape of a posteriorly directed 
hook in the sagittal plane. 
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Figure 2.4: Representation of a dissected brain showing the precentral knob (indicated by arrows), which can look like an 
inverted omega (A) or a horizontal epsilon (B) when cut axially, and like a hook when cut sagittaly (C) [10]. 
 
2.3. Energy metabolism in the brain 
 
Like in all organs, energy metabolism in the brain is necessary for the basic processes of cellular 
work, such as chemical synthesis and chemical transport [1]. Still, the particular work done by the 
brain, which is the generation of electrical activity required for neuronal signalling, such as the 
generation of an action potential and the release of neurotransmitter at a synapse, requires a high 
level of energy metabolism [11].  
In biologic systems the free energy necessary for these tasks is primarily stored in relative 
proportions of three nucleotides: adenosine triphosphate (ATP), adenosine diphosphate (ADP) and 
adenosine monophosphate (AMP), being ATP the main source of energy for cells [11]. ATP 
production is dependent on the combination of glucose and oxygen. The metabolism occurs in two 
stages: glycolysis and the trans-carboxylic acid (TCA) cycle (also known as the citric acid cycle or the 
Krebs cycle) [11, 12]. Glycolysis does not require oxygen but the further metabolism of glucose 
though the TCA cycle requires oxygen and produces much more ATP (see Figure 2.5). 
 Oxidative glucose metabolism involves many steps and different reactions which are catalyzed by 
different enzymes within the cell. At the end of the process, carbon dioxide and water are produced, 
and an additional 38 ATP molecules are created. The overall metabolism of glucose is then  
 
𝐶6𝐻12𝑂6 + 6𝑂2 → 6𝐶𝑂2 + 6𝐻2𝑂 (+38𝐴𝑇𝑃)  
   
As we know, regional energy requirements are different across the brain, so the delivery of 
oxygen and glucose is also distinct in different regions of the brain. 90% of the glucose metabolized 
requires oxygen [1], therefore neuronal metabolic activity can be directly associated to oxygen 
consumption. Furthermore, we know that blood flow is the responsible for delivering glucose and 
oxygen to the brain tissues. According to this, neuronal activation induces an increase of the oxygen 
consumption, which is accomplished with an increase of blood flow [1].   
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Figure 2.5: Schematic diagram of the main steps of cerebral energetic metabolism (adapted from [1]).   
 
2.4. Cerebral blood flow 
 
The vascular system that supplies blood to the brain is organised on a spatial scale that spans a 
range of four orders of magnitude, from the diameter of a capillary (about 10 𝜇𝑚) to the size of a 
major artery (about 3 𝑐𝑚) [1]. The complexity of the vascular system of the brain can be appreciated 
from images in Figure 2.6. In short, the architecture of the vascular tree shows distinct organisation 
on a spatial scale as small as a few hundred micrometers. 
 
 
Figure 2.6: Vascular system of the brain [1]. In the left image there’s an MR angiogram showing the main arteries supplying 
blood to brain tissues, and the veins which drain that tissues. In the right image a microscopic view is presented, showing 
the complex geometry of small vessels: arterioles, capillaries and venules.  
 
As suggested earlier, cerebral blood flow (CBF) delivers glucose and oxygen to the brain, so it is 
obvious to assume that local CBF varies with neural activity. The measurement of CBF changes with 
activation assumes a vital importance in the understanding of basic physiological processes and 
pathologies. Different functional imaging techniques, including fMRI, rely on CBF changes, so is 
important to understand what it is and how it can be measured. 
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2.4.1. The Meaning of Perfusion 
 
The term perfusion is generally used to describe the process of nutritive delivery of arterial blood 
to a capillary bed in the tissue and cells. Since cerebral haemodynamics is one of the key aspects in 
functional neuroimaging, it is important to describe it in terms of a number of clearly defined 
variables. One of these variables is the cerebral blood flow, defined as the rate of delivery of arterial 
blood to the capillary beds of a particular mass of tissue [1], as illustrated in Figure 2.7 (a). In this 
idealized tissue vasculature, the flow rates through both capillary beds are designated 𝐹1 and 𝐹2 
(expressed in millilitres per minute), and if these vessels feed a volume of tissue  𝑉, then CBF is 
simply (𝐹1 + 𝐹2)/𝑉. For convenience, a common unit for CBF is millilitres of blood per 100 grams of 
tissue per minute, and a typical average value in the human brain is  60 𝑚𝑙/100𝑔/𝑚𝑖𝑛 [1]. However, 
in some circumstances it is convenient to express CBF as flow delivered to a unit volume of tissue 
rather than a unit of mass of tissue. For instance, in imaging applications a signal is measured from a 
particular volume in the brain, and the actual mass of tissue within that volume is not known. 
Because the density of brain is close to 1 𝑔/𝑚𝑙 [1], CBF values expressed in these units are similar (it 
means that 60 𝑚𝑙/100𝑔/𝑚𝑖𝑛 is equivalent to 0.01 𝑠−1).    
The cerebral blood volume (CBV) is the fraction of the tissue volume occupied by blood vessels, 
and a typical value for the brain CBV is 4% (CBV = 0.04) [1]. The CBV is a dimensionless number 
(millilitres of blood vessel per millilitre of tissue), and generally refers to the entire vascular volume 
within the tissue. However, in some occasions it’s important to subdivide total CBV into arterial, 
capillary and venous volumes, where typical estimate numbers are 5% for the arterial volume and 
95% equally divided for capillaries and veins [1]. 
The velocity of blood in the vessels is also an important physiological parameter, which varies 
from tens of centimetres per second in large arteries to as slow as one millimetre per second in the 
capillaries [1]. 
 
 
Figure 2.7: The meaning of perfusion (adapted from [1]). (a) Illustration of blood vessels within a small element tissue for 
cerebral blood flow definition. (b) Demonstration of the incapacity to calculate CBF with blood volume and velocity.   
 
Although CBF, CBV and blood velocity are all important aspects of the perfusion state of tissue, 
they are distinct physiological quantities [13]. From the preceding definitions, it can be noticed that 
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CBF does not explicitly depend on either blood volume or the velocity of blood in the vessels, i.e., an 
increase in CBF with brain activation could occur through a number of different changes in blood 
volume or blood velocity. In Figure 2.7 (b) two idealized capillary beds are shown, one with two sets 
of shorter capillaries, and one with a single set of capillaries twice as long. Both beds show the same 
blood velocity and CBV. However, CBF is twice as large in the top bed with two sets of shorter 
capillaries. The missing piece that does differ between the two scenarios and is responsible for this 
difference is the capillary transit time [13]. In the bottom bed the capillary transit time is twice as 
long. And it is transit time, rather than blood velocity, that is directly connected to CBV and CBF. The 
relation between CBV, CBF and the mean transit time (𝑀𝑇𝑇) through the volume CBV is known as 
the central volume principle, and is defined as: 
 
𝑀𝑇𝑇 = 𝐶𝐵𝑉/𝐶𝐵𝐹 
 
For a CBF of 60 𝑚𝑙/100𝑔/𝑚𝑖𝑛 (0.01 𝑠−1) and a typical CBV of 4%, from this equation 𝑀𝑇𝑇 is  4 𝑠.  
In summary, the definition of CBF involves some subtleties that have to be considered when we 
want to measure it. Some of these subtleties consist in particular properties of the measuring 
technique that we use. For this reason an accurate approach is necessary to properly measure CBF.   
 
2.4.2. Measuring CBF 
 
Numerous imaging techniques have been developed and applied to evaluate brain hemodynamics 
[14]. Most of those techniques rely on mathematical models developed at the beginning of the 
century, giving similar information about brain hemodynamics in the form of different parameters 
such as CBF or CBV. For that purpose, they use different tracers to mimic perfusion and have 
different physical principles and different technical requirements. 
 
2.4.2.1. Diffusible vs. Intravascular tracers 
  
The various tracers used in brain studies usually fall into one of two basic classes, diffusible tracers 
and intravascular tracers, which differ in their volume of distribution [1, 2]. Nitrous oxide, for 
example, freely diffuses out the capillary bed and fills the entire tissue space, so its volume of 
distribution is essentially the whole brain volume. On the other hand, an agent that remains in the 
blood has a volume of distribution that is much smaller, only about 4% of the total brain volume [1]. 
For an intravascular agent the time constant for the venous blood to equilibrate with the arterial 
blood is corresponding shorter, or in other words, for the same flow, the volume of distribution of an 
intravascular agent is quickly filled because the blood volume is only a small fraction of the total 
tissue volume [1]. 
This difference in the equilibrium times directly affects what can be measured with diffusible and 
intravascular tracers [1]. Considering that the tissue concentration of an agent (which is injected into 
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blood) is measured over time, once the agent has reached equilibrium within its volume of 
distribution, the tissue concentration of the agent is independent of flow but provides a robust 
measure of the volume of distribution. Therefore, an intravascular agent provides a robust 
measurement of CBV, because that is its volume of distribution, but a poor measurement of flow, 
because it equilibrates too quickly. In contrast, a diffusible tracer provides a robust measurement of 
flow because the time for equilibrium is much longer.  
These basic ideas suggest that the perfusion techniques applied to measure local CBF use 
diffusible tracers.          
 
2.4.2.2. Techniques to measure CBF 
 
The main imaging techniques dedicated to brain hemodynamics are positron emission 
tomography (PET), single photon emission computed tomography (SPECT), Xenon-enhanced 
computed tomography (XeCT), dynamic perfusion computed tomography (PCT), Doppler ultrasound, 
MRI dynamic susceptibility contrast (DSC) and arterial spin labelling (ASL). 
PET is a powerful diagnostic tool, considered in early times the gold standard technique for brain 
perfusion evaluation [14], that provides tomographic images of quantitative parameters describing 
regional CBF (rCBF), regional CBV (rCBV), regional oxygen extraction fraction (rOEF), regional cerebral 
metabolic rate of oxygen (rCMRO2) or glucose, neurotransmission processes, etc. These images result 
from the use of different substances of biological interest labelled with positron emitting 
radioisotopes. The most commonly used tracer to measure CBF is H2
15O [15], which is administered 
directly by intravenous injection. A few minutes scan is performed and its results combined with an 
arterial blood sampling measurement, performed in order to obtain the input function, leads to 
quantitative CBF maps. 
SPECT was introduced soon after PET. Besides some technical aspects, like the equipment 
involved, the main difference between SPECT and PET is that the first one uses radioisotopes which 
emit gamma photons, such as 99mTc [15]. Perfusion PET and SPECT methods afford whole brain 
coverage and provide valuable information, giving quantitative CBF maps [14, 15]. However, the 
spatial resolution of these nuclear imaging studies ranges from ≈ 4 to 6  𝑚𝑚 [14]. Its clinical 
applications are still limited due to their high price and specific technical requirements. In addition to 
the access to radiopharmaceuticals, PET requires the access to a cyclotron near the administration 
local. Furthermore, in PET or SPECT examinations, the whole body is exposed to radiation. 
After the introduction of computed tomography (CT) two methods for evaluating CBF were 
developed, both based on administration of a contrast agent. Dynamic PCT uses first-pass tracer 
methodology after bolus infusion of an intravenous iodinated contrast material, and provides CBF, 
CBV, MTT and blood brain barrier (BBB) permeability [14]. The other CT method uses stable xenon 
gas (Xe). When inhaled, this gas dissolves into the blood, freely crosses the BBB and enters the brain, 
and then its concentration in the brain can be directly measured with a CT scanner [14]. Unlike most 
methods of imaging CBF, XeCT is truly quantitative and has been found to be accurate even at very 
low and very high flow rates. A spatial resolution 2  𝑚𝑚 is routinely available [14]. An additional 
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advantage is its rapid elimination, which makes repeated scanning under different conditions 
possible. Nonetheless, Xe is a narcotic gas, and even if it was used in low doses, some side effects can 
be seen, like euphoria, raising the need of permanent medical assistance during the imaging 
procedure. Moreover, dynamic PCT and XeCT use ionizing radiation, and as PET and SPTEC methods, 
they are not completely non-invasive techniques [15]. 
Although different in nature from other imaging techniques described hereby and accordingly 
limited in spatial resolution, Doppler ultrasound offers the advantage of being non-invasive and 
repeatable as often as clinically indicated at the patient’s bedside [14]. It doesn’t involve radiation, 
doesn’t require any contrast medium, and is free of any known adverse effect. Considering these 
facts, ultrasound Doppler technology may represent a convenient tool for the measurement of blood 
flow volume in the internal carotid artery as a correlate for CBF in the corresponding hemisphere 
[14].   
MRI also provides two approaches to measuring CBF. Like first-pass PCT, the first of these  
approaches, DSC, implies the administration of a contrast agent [14, 15] that remains intravascular. 
In addition, MR contrast agents alter image intensity indirectly affecting the surrounding tissues. The 
other MRI method for imaging CBF, ASL, does not require administration of a contrast agent, and 
provides direct measures of CBF changes [15]. Most importantly, this MR method requires neither 
exposure to form of radiation (as XeCT), nor administration of a contrast agent (as MR DSC), and 
measures can be repeated as often as required. A more detailed discussion of this last technique will 
be given in Chapter 3. 
  
2.5. Brain Activation 
 
The real nature of the coupling between CBF and CMRO2 during activation is still debated. 
However, the tomographic techniques have provided experimental data for the generation of some 
theories that explain the energetic metabolism of the brain. 
The primary finding is that CBF increases substantially during brain activation [16]. The increase is 
localised and is a graded response in the sense that the magnitude of the flow change is often 
correlated with other measures of the degree of neural activity. The second finding is that CMRO2 
increases much less than CBF [16]. The main reason for that or at least the most accepted one 
nowadays, is that this unclear disconnection between CBF and CMRO2 is due to a large and 
disproportional essential increase on CBF to supply a small increase of the oxygen consumption 
during activation [17]. This oxygen limitation model is based on two assumptions: the first one is that 
the supply of oxygen to the tissue is limited by BBB, which means that only a small rate of the 
supplied oxygen is available for metabolism. The second one is that CBF increasing is accompanied by 
an increase of blood velocity in the capillaries rather than the capillary recruitment [17]. In summary, 
the result of this imbalance in the changes of CBF and CMRO2 is a substantial drop in oxygen 
extraction like is shown in Figure 2.8. 
The scheme of Figure 2.8 implies that CBF and metabolism are linked under physiological 
conditions but can be uncoupled by selective manipulations or under particular pathophysiological 
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conditions [17]. With the introduction of techniques such as fMRI, it was possible to piece together 
an empirical picture of the physiological changes that accompany brain activation and form the basis 
for functional neuroimaging. 
 
 
Figure 2.8: Physiological changes that accompanying brain activation (adapted from [1]).  
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Chapter 3  
Functional Magnetic Resonance Imaging 
 
Functional magnetic resonance imaging (fMRI) provides a sensitive, non-invasive tool for mapping 
patterns of activation in the working human brain. However, how this tool works is far from obvious, 
and to understand the strengths and limitations of fMRI it is necessary to delve into the nature of the 
magnetic resonance (MR) signal and how it can be measured and affected by brain activation. 
 
3.1. Physics principles of MRI 
 
Magnetic Resonance Imaging (MRI) is a non-invasive imaging technique that allows to produce 
high quality images of living organisms [1]. This technique is also known as magnetic resonance 
tomography or nuclear magnetic resonance. 
MRI is based on the principles of nuclear magnetic resonance. It measures spatial variations in the 
phase and frequency of the radio-frequency energy being absorbed and emitted by the imaged 
object [18].  
There is a huge amount of atoms in the human body. The ones with nuclei with an odd number of 
protons and neutrons possess a property called spin, which is its intrinsic angular momentum and 
can attain any value multiple of 1/2. When these spins are placed in a strong external magnetic field 
(𝐵0) they precess around an axis along the direction of the field, aligning in two energy “eigenstates” 
(analogous to the Zeeman Effect): one low-energy and one high-energy, which are separated by a 
very small splitting energy [18]. This precession frequency 𝜈 is called the Larmor frequency and is 
obtained (with the gyromagnetic ratio of nucleus,  𝛾) from the Larmor equation:  
 
𝛾𝐵0 = 𝜈          Equation 3.1 
 
After exposing the object of study to a magnetic field, a transient radio frequency (RF) pulse at the 
characteristic Larmor frequency is briefly applied, in a plane perpendicular to  𝐵0. This RF pulse 
excites some of the spins in the lower energy state at their resonant frequency, disturbing the 
aligned hydrogen nuclei, thus causing a disruption of the equilibrium. From this disturbance of 
equilibrium, two effects arise: longitudinal and transverse magnetisation [18]. So, the RF pulse causes 
an oscillatory effect on the component of the magnetisation vector (𝑀) parallel to the z axis, and a 
small component of the magnetisation will be in the x-y axis, which can be detected. The angle that 
the net magnetisation vector rotates is commonly called the flip angle [19].  
When the RF pulse is turned off, the transverse vector component produces an oscillating 
magnetic field which induces a small current in a receiver coil. This signal is called free induction 
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decay (FID) [19]. In an idealized MR experiment, the FID decays approximately with a time constant 
called 𝑇2, which is the time that takes transverse magnetisation to decrease 63% of its value when 
the RF pulse is turned off. However, in practical MRI small differences in the static magnetic field at 
different spatial locations (inhomogeneities) cause the Larmor frequency to vary across the body 
creating destructive interference which shortens the FID. The time constant for the observed decay 
of the FD is called the 𝑇2
∗ relaxation time, and is always shorter than 𝑇2. Also, when the RF pulse is 
turned off, the longitudinal magnetisation starts to recover exponentially with a time constant 𝑇1, 
which is the time for the magnetisation to return to 63% of its original length [19].  
In MRI, the static magnetic field is caused to vary across the body (by applying field gradients 
using appropriate coils), so that different spatial locations become associated to different precession 
frequencies. Usually these field gradients are pulsed, and it is the almost infinite variety of RF and 
gradient pulse sequences that gives MRI its versatility. The application of a field gradient destroys the 
FID signal, but this can be recovered and measured by a refocusing gradient (to create a so-called 
gradient echo), or by a RF pulse (to create a so-called spin echo). The whole process can be repeated 
when some longitudinal relaxation has occurred and the thermal equilibrium of the spins has been 
more or less restored [19]. 
Typically in soft tissues 𝑇1is around one second while 𝑇2 and 𝑇2
∗  are a few tens of milliseconds, 
but these values vary widely between different tissues (and different 𝐵0), giving MRI its tremendous 
soft tissue contrast (see Table 3.1) [19]. 
 
Table 3.1 
𝑇1 and 𝑇2 values of CSF, grey and white matters for a magnetic field of 3 Tesla [20] 
Tissue 𝑻𝟏 (𝒎𝒔) 𝑻𝟐 (𝒎𝒔) 
White matter 832 110 
Grey matter 1331 80 
CSF 2500 250 
 
Thus, image contrast is created by differences in the strength of the MR signal recovered from 
different locations within the sample, which depends upon the relative density of excited nuclei 
(usually water protons), on differences in relaxation times of those nuclei after the pulse sequence 
[18]. Furthermore, image contrast relies on other parameters (controlled by users): the echo time 
(TE) which is the time between the centre of the initial RF pulse (in a pulse sequence) and the centre 
of the signal echo formed by that pulse, and the repetition time (TR) which is the amount time that 
exists between successive excitation pulse sequences (see Figure 3.1) [19]. 
 
 
Figure 3.1: Different image contrasts [19]. From left to right: T1-weighted, proton density-weighted and T2-weighted images. 
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3.2. Image acquisition 
 
The quality and contrast of the image acquired with MRI can be manipulated by the use of 
different image acquisition techniques. The main steps usually consist on slice selective excitations, 
frequency encoding and phase encoding, which result in data being collected in a spatial frequency 
space – the k-space1. Image reconstruction is then accomplished by performing a 2D inverse Fourier 
transform of the raw data. The exact timings and characteristics of the acquisition determine the 
resolution and contrast of the image [19]. Many methods of image acquisition have been developed 
in order to reduce the image acquisition time, which is very useful for functional studies.  
Gradient-echo (GE) - echo-planar imaging (EPI) sequences are the commonly used in such 
applications. This acquisition module is based on the collection of the data necessary to reconstruct 
an image using one set of echoes after a single RF excitation and a short phase encoding gradient 
between each echo [14]. The EPI sequence diagram is showed in Figure 3.2 (a). 
 
Figure 3.2: (a) EPI sequence diagram and (b) EPI k-space coverage order during one TR (adapted from [14, 19]).  
 
Figure 3.2 (b) shows the k-space sampling trajectory determined by the EPI sequence. All k-space 
lines are acquired in only one shot and each line is acquired in the opposite direction relatively to the 
previous one. This effect results in the phase accumulation (N) in different directions in odd and even 
lines of the k-space. After image reconstruction it leads to an N/2 shift of the object representation, 
which can lead to the Nyquist ghosting effect. The main advantages of EPI readout are the short 
acquisition time, efficiency, regular k-space coverage and acceptable signal to noise ratio (SNR), and 
it can be combined with many spin preparation methods. However, the EPI acquisition is very 
sensitive to susceptibility induced field changes and inhomogeneities which may be useful for fMRI 
studies [21]. However, this property can also lead to signal drop-out and image distortions. In fact, 
image distortion occurs frequently near the sinuses, due to the magnetic field differences between 
the air (in the sinuses) and the brain tissues [14]. The readout, x, direction of the k-space is acquired 
with a high bandwidth (fast acquisition), while the phase-encoding direction, y, is acquired more 
slowly. The image quality depends on the echo spacing for a given resolution and phase errors, and 
consequently geometric distortions, appear predominantly in the phase encoding direction. 
                                                          
1
 K-space is a temporary virtual space enclosing the phase and frequency of imaging data and it functions to simplify 
their conceptualization.   
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3.3. BOLD functional MRI 
 
Although susceptibility effects can produce artefacts when imaging the brain (as mentioned in the 
previous section), they are the basis of the generation of the blood oxygen level dependent (BOLD) 
contrast that is the basis of most functional MRI studies [22]. 
The magnetic susceptibility effect at the basis of BOLD experiments arises from the biophysics of 
the haemoglobin molecule, which provides oxygen required for aerobic energy metabolism [23]. As 
blood leaves the lungs, oxygen becomes loosely and reversibly bonded to an iron atom that lies at 
the center of the heme molecule within the haemoglobin complex. When delivered to tissue, oxygen 
separates from the heme molecule exposing electrons from the iron atom. The unpaired iron 
electrons alter the lines of the magnetic field near the deoxyhemoglobin molecule, which causes 
slight dephasing of the spins of the hydrogen nuclei in proximal water molecules of both blood 
vessels and adjacent tissues [23, 24]. These effects occur because haemoglobin is diamagnetic when 
oxygenated but paramagnetic when deoxygenated. The MR signal of blood is therefore slightly 
different depending on the level of oxygenation. Higher BOLD signal intensities arise from increases 
in the concentration of oxygenated haemoglobin since the blood magnetic susceptibility now more 
closely matches the tissue magnetic susceptibility [23].  
Chapter 2 laid the foundation for understanding how fMRI based on BOLD effect works. Brain 
activation is characterized by a drop in the local oxygen extraction fraction (OEF) and a corresponding 
drop in the local concentration of deoxyhemoglobin, which produces a small increase in the MR 
signal (see Figure 3.3) [24]. Thus, using deoxyhemoglobin as an endogenous tracer, regional brain 
activation can be mapped with 𝑇2
∗ sensitive pulse sequences, such as the GE sequence. 
 
 
Figure 3.3: Schematic illustration of hemodynamic changes during neuronal activity [25]. From the basal state (resting) to 
activated state a decrease of deoxyhemoglobin concentration occurs in the capillaries and venules, resulting in an increase 
in the BOLD signal intensity. 
 
In summary, BOLD contrast does not reflect a single physiological process, but rather represents 
the combine effects of cerebral blood flow (CBF), cerebral blood volume (CBV) and cerebral 
metabolic rate of oxygen (CMRO2) [24]. Furthermore, the sluggish response of the vascular system to 
neural events delays, disperses and smooths over time the underlying neural signal [22]. This implies 
that the observed BOLD signal is generally a composition of signals produced by separate neural 
events. The MR signal plots in Figure 3.4 show an idealization of the BOLD signal due to brief 
stimulation. This signal, also called hemodynamic response function (HRF), is complex, with an initial 
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drop followed by the rise to a single maximum, a decline, and an undershoot before returning to 
baseline [21]. The HRF characteristics vary between different regions of the brain and depend on the 
stimulus and its duration [26]. A detailed biophysical explanation of the complex shape of the BOLD 
signal is a current area of research. 
 
Figure 3.4: The typical hemodynamic response function (HRF): BOLD response to a brief stimulus (adapted from [18]). 
 
3.4. Perfusion functional MRI – ASL 
 
Arterial spin labeling (ASL), also called arterial spin tagging, is a non-invasive MRI method to 
measure brain perfusion.  
The overall goal of all existing ASL techniques is to produce a flow-sensitized image or labelled 
image and a control image in which the static tissue signals are identical, but where the 
magnetisation of the inflowing blood differs [27]. The subtraction control-label (𝑀𝑐𝑜𝑛𝑡𝑟𝑜𝑙 −𝑀𝑡𝑎𝑔 ) 
yields a signal difference ∆𝑀 that directly reflects local perfusion, because the signal from stationary 
tissue is completely eliminated (Figure 3.5). The label is usually performed by inverting or saturating 
the spins of water molecules of the blood supplying the imaged region [27, 28]. Once the labelled 
blood spins are allowed to reach the capillary bed, which is accomplished with a delay between the 
labelling and image acquisition, they exchange with tissue water and thereby give rise to the 
perfusion signal. The signal difference, which is only 0.5 − 1.5% of the full signal, depends on many 
parameters such as the flow itself, the 𝑇1 of blood and tissue, as well as the time it takes blood to 
travel from the labelling slab to the imaging region [27]. Multiple repetitions are needed for ensuring 
sufficient SNR, and a model of the perfusion signal is usually used in order to quantify CBF. 
 
 
Figure 3.5: Schematic description of a perfusion weighted image (∆𝑀) obtained by subtraction of the labelled images from 
the control images, using the FAIR scheme (adapted from [27, 28]). 
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3.4.1. Spin labelling methods: CASL and PASL 
 
There are two main classes of ASL techniques: continuous ASL (CASL) and pulsed ASL (PASL). 
Although both approaches share a similar basis, they present different benefits and limitations that 
affect their abilities to quantify perfusion [27]. 
In CASL, arterial blood water is continuously and selectively labelled as it passes through a 
labelling plane, typically applied at the base of the brain. The first perfusion method using ASL was 
introduced by Detre et al. in 1992 [29]. It employs a combination of repeated saturation in the neck 
region and imaging in a brain slice. This approach had been used earlier by Williams et al. [30], but 
for MR angiographic applications. This type of adiabatic inversion of the arterial magnetisation is 
realized using a 3 𝑠𝑒𝑐𝑠 continuous RF pulse while applying a magnetic field gradient in the flow 
direction. The moving arterial spins will then experience a slow variation of the resonance frequency, 
which will result in their inversion [29]. Typically the thin inversion slab is selected at the level of the 
common carotid, and the spins in blood that flows through this plane will be inverted. When they 
reach the region of interest (imaging slab), the longitudinal magnetisation has decreased due to 𝑇1 
relaxation, but it’s still different from the relaxed tissue magnetisation [31]. So, the arterial blood 
reduces the total longitudinal magnetisation of the imaging slab. For the control experiment, two 
closely spaced inversion planes (double adiabatic inversion) are used: the magnetisation gets 
inverted while crossing the first plane and returns theoretically to its original state during the 
passage through the second plane [31]. This experiment is shown in Figure 3.6.  
The PASL approach labels a thick slab (10 − 15 𝑐𝑚) of arterial blood at a single instance in time, 
and the imaging is performed after a time long enough for that spatially labelled blood to reach the 
tissue and exchange at the region of interest [27]. In 1994, Edelman et al. [32] proposed the first 
pulsed ASL scheme, known as echo planar imaging and signal targeting with alternating 
radiofrequency, EPISTAR. For the labelled image a single 180° RF pulse is applied in the presence of a 
field gradient to invert the longitudinal magnetisation of the protons in a slab inferior to the image 
slice (see Figure 3.7).  
 
 
Figure 3.6: Continuous arterial spin labelling experiment (adapted from [7]).  
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Figure 3.7: Pulsed arterial spin labelling experiment:  (on the left) EPISTAR experiment and (on the right) localisation of 
labelling pulses used in EPISTAR and FAIR experiments (adapted from [7]). 
 
For the control image two 180° + 180° pulses of half the power are applied at the same proximal 
location [32]. Shortly afterwards, an alternative to this asymmetric method of labelling was proposed 
by Kwong et al. and Kim [33], who named it flow alternating inversion recovery (FAIR). In this 
approach, the label is symmetrically applied using a non-selective inversion pulse (Figure 3.7), while 
the control employs a concomitant slice selective gradient pulse. One third technique, named 
proximal inversion with a control for off-resonance effects (PICORE) was developed by Wong et al. 
[34], and uses a labelling scheme similar to EPISTAR. The only difference is that the inversion slab in 
the control acquisition was replaced by an RF pulse applied at the same frequency as in the label 
experiment but in the absence of a magnetic field gradient [34]. Furthermore, there’s a wide range of 
labelling sequences available today, which are variants of these three principal techniques.  
Comparing both spin labelling schemes, although CASL provides stronger perfusion contrast, it is 
more difficult to implement than PASL because of its hardware demands, and it deposits a higher 
level of RF power into the subject. The long labelling pulses in CASL also partially excite the imaging 
slices through an effect termed magnetisation transfer [27]. This has to be balanced during the 
control acquisitions, in order to accurately quantify CBF. PASL methods, on the other hand, require a 
gap between the image slice and the inversion slab to avoid imperfect slice profile effects [27].   
 
3.4.2. Quantification 
 
Accurate perfusion measurements require careful consideration of both data collection and 
analysis. To obtain a quantitative perfusion map from the difference image (∆𝑀), an accurate model 
of the system is required. The difference signal is dependent on a number of factors, including: 
inversion efficiency, blood  𝑇1, tissue  𝑇1, capillary permeability, arrival time and perfusion [17].  
Figure 3.8 shows the tissue magnetisation ∆𝑀 with time after the start of labelling at 𝑡 = 0. As we 
can see, there are three parts of this curve: part 1 has no signal since the labelled protons have yet to 
reach the tissue volume; in part 2 the signal increases as labelled protons enter the volume; and in 
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part 3 the signal decreases due to longitudinal relaxation and outflow after the end of incoming 
arterial (labelled) blood [6]. 
 
 
Figure 3.8: A schematic of the idealized magnetisation difference curve with time (adapted from [6]). 
 
The perfusion curve describes the passage of the labelled spins through the vasculature into the 
tissues. Mathematically, it is possible to model the dynamics of the ASL signal considering that this 
signal comes from a bolus of labelled spins travelling through the vasculature, convolved with a 
tissue residue function [35]. CBF is then calculated using the deconvolution of the tissue curve 𝐶(𝑡) 
by the measured arterial input function (AIF) 𝐶𝑎(𝑡): 
 
𝐶 𝑡 = 𝐶𝐵𝐹𝐶𝑎 𝑡 𝑅 𝑡 = 𝐶𝐵𝐹  𝐶𝑎 𝑡 𝑅 𝑡 − 𝜏 𝑑𝜏
𝑡
0
         Equation 3.2 
 
where  𝑅 𝑡  is the residue function that describes the fraction of contrast that remains in the system 
after a given time 𝑡. 
Buxton et al. [36] described a General Kinetic Model for the magnetisation difference between 
labelled and control measurements using the convolution integral from Equation 3.3: 
 
∆𝑀 𝑡 = 2𝑀0B𝑓  𝑐 𝜏 𝑟 𝑡 − 𝜏 𝑚 𝑡 − 𝜏 𝑑𝜏
𝑡
0
     Equation 3.3 
 
where 𝑀0B  is the equilibrium magnetisation of arterial blood, c t  is the delivery function, and 
𝑟 𝑡 − 𝜏 𝑚 𝑡 − 𝜏  is the fraction of that magnetisation that remains at time 𝑡. Applying single-
compartment kinetics in which each voxel is considered a single well mixed compartment, i.e., 
assuming instantaneous mixing between arterial blood and tissue [36], Equation 3.3 can be re-
written as Equation 3.4 for all PASL methods: 
 
∆𝑀 𝑡 =  
0                                                                                          0 < 𝑡 < 𝛿𝑡          
2𝑀0𝐵𝑓 𝑡 − 𝛿𝑡 𝛼𝑒
−𝑡/𝑇1𝑏𝑞𝑝(𝑇1𝑏 ,𝑇1𝑡 ,𝑇𝑒𝑥 ,𝑓, 𝜆, 𝑡)       𝛿𝑡 < 𝑡 < 𝜏 + 𝛿𝑡 
2𝑀0𝐵𝑓𝜏𝛼𝑒
−𝑡/𝑇1𝑏𝑞𝑝(𝑇1𝑏 ,𝑇1𝑡 ,𝑇𝑒𝑥 ,𝑓, 𝜆, 𝑡)                     𝜏 + 𝛿𝑡 < 𝑡           
    Equation 3.4 
 
with 
 
𝑞𝑝 =
 
 
 
 
 𝑒
𝑘𝑡 𝑒−𝑘𝛿𝑡 − 𝑒−𝑘𝑡 
𝑘(𝑡 − 𝛿𝑡)
                        𝛿𝑡 < 𝑡 < 𝜏 + 𝛿𝑡
𝑒𝑘𝑡 𝑒−𝑘𝛿𝑡 − 𝑒−𝑘(𝜏+𝛿𝑡) 
𝑘(𝑡 − 𝛿𝑡)
               𝜏 + 𝛿𝑡 < 𝑡          
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and 
 
𝑘 =
1
𝑇1𝑏
−
1
𝑇1
′           and        
1
𝑇1
′ =
1
𝑇1
+
𝑓
𝜆
 
 
where 𝑓 is the CBF in ml-blood/ml-tissue/sec, T1𝑏  and T1t  are the T1 of arterial blood and tissue, 
respectively, Tex  is the transit time from the distal edge of the tag region to the capillary bed where 
tagged blood water exchanges into brain parenchyma, 𝛼 is the inversion efficiency, 𝜆 is the blood-
brain partition coefficient of water, 𝛿𝑡 is the arterial transit time and 𝜏 is the time width of the label. 
𝑞𝑝  is a correction factor for the fact that the rate of decay of the tag switches from that of blood to 
that of tissue after exchanging into tissue, and for clearance of the tag by flow. Under most 
conditions 𝑞𝑝  is close to unity [36].  
As we can see, the raw difference signal ∆M, although proportional to 𝑓, does not provide 
sufficient data to construct a perfusion map, primarily because 𝛿𝑡 and 𝜏 are not know. M0B  and  T1B  
are spatially invariant constants that can be estimated either from imaging measurements or 
assumed from literature values and simply scale the perfusion measurement. The parameters 𝛿𝑡 and 
𝜏 are both dependent on vessel geometry and distribution of flow velocities [34]. Then, two 
modifications of the basic pulsed ASL experiment were introduced by Wong et al. [37] in order to 
eliminate the dependence of ∆M on 𝛿𝑡 and 𝜏: QUIPSS (quantitative imaging of perfusion using a 
single subtraction) and QUIPSS II (second version of QUIPSS). Although they seem nearly identical in 
implementation, these modifications have very different properties, and can be combined with 
different labelling techniques [37]. 
The basic principle of these techniques is the application of a saturation pulse at time 𝑇𝐼1 after 
the application of the tag to produce a well defined bolus of contrast. QUIPSS II is identical to 
QUIPSS, except that the saturation pulse is applied to the tagging region rather than the imaging slice 
[37]. In QUIPSS II, at time 𝑇𝐼1 after the application of the tag, a saturation pulse is applied to the 
tagging region in both tag and control experiments, thus effectively cutting off the tail end of the 
inflowing tag. This delivers a bolus of tagged blood of time width 𝑇𝐼1 to the imaging slice. After an 
additional delay, an image is acquired at time 𝑇𝐼2. Afterwards, Wen-Ming Luh et al. [38] developed a 
new approach called Q2TIPS (QUIPSS II with thin-slice 𝑇𝐼1 periodic saturation), which improved the 
accuracy of perfusion measurements. In Q2TIPS, the QUIPSS II saturation pulse is replaced by a 
periodic train of thin-slice saturation pulses at the distal end of the tagged blood, which not only has 
sharper edges as also has a greater field homogeneity over the slice thickness than a thick-slice pulse 
[38]. 
According to this theory, if 
 
𝑇𝐼1 ≤ τ         Equation 3.5 
  
𝑇𝐼2 ≥ 𝑇𝐼1 + 𝛿𝑡        Equation 3.6 
 
then the signal is independent of both 𝛿𝑡 and 𝜏, and is given by [37, 38] 
 
∆M TI2 = 2M0BfTI1e
−TI2/T1b q(T1b , T1t , Tex , f, λ, TI2)       Equation 3.7 
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The condition on 𝑇𝐼1 (Equation 3.5) is that it is shorter than the natural time width of the tagged 
bolus. If this is satisfied then the time width of the bolus is known to be  𝑇𝐼1. The condition on 𝑇𝐼2 
(Equation 3.6) is required to allow for the delivery of the entire bolus to the imaging slice [37]. If this 
is satisfied, then the CBF can be calculated from [39] 
 
𝐶𝐵𝐹 =
𝜆∆𝑀
2𝛼𝑀0𝑇𝐼1𝑒
−𝑇𝐼2/𝑇1𝑏
       Equation 3.8 
 
where 𝑀0 is the tissue magnetisation. 
Nevertheless, there are several parameters that, if not accounted, can lead to significant errors in 
perfusion quantification. 
 
3.4.2.1. The role of arterial transit time 
 
Buxton et al. [36] demonstrated theoretically that one of the most important parameters needed 
for quantification of the ASL signal is the arterial transit time, which even in healthy subjects differs 
across the brain, being longest in distal branches. In most PASL approaches, information on perfusion 
is assessed at a single inversion time point  𝑇𝐼2, and therefore without information about the transit 
time. Sequences like QUIPSS II and Q2TIPS were developed to render ASL more transit-time 
insensitive. The usage of these modifications is really an advantage in volunteers and patients 
without vascular diseases where the difference in transit time is small, as well for quantitative 
functional studies where it is known that the transit time changes are small between baseline and 
activation conditions [37]. 
However, these methods will fail in patients with cerebrovascular diseases, where the transit time 
can be long in affected areas due to low perfusion velocity and, in some cases, extensive collateral 
perfusion. In these cases, the problem can be solved by acquiring images at multiple inversion times 
and therefore measuring the entire ∆M curve (Figure 3.8) [5]. The standard sequences, in which a 
single time point is acquired at a time, are generally too lengthy to be suitable for clinical 
examinations. Gu nther et al. [40] introduced an elegant solution to this problem using a Look-Locker-
like readout to measure the ASL signal at multiple 𝑇𝐼2 in a single scan. A similar scheme was also 
implemented using the transfer insensitive labelling technique (TILT) by Hendrikse et al. [41]. 
 
3.4.2.2. Vascular artefacts 
 
Vascular artefacts, associated with the inflow of labelled arterial blood into the arteries, can 
introduce important errors in CBF quantification. In a typical tissue voxel a range of many vessel sizes 
can be found (Figure 3.9), not all of which contain blood that will perfuse this tissue. The blood in the 
larger vessels is destined to perfuse tissue further downstream and so its signal must be removed. 
To solve this problem, Ye et al. [42] proposed the use of bipolar crusher gradients to eliminate the 
signal from the large feeding arteries in CASL and PASL sequences. Another solution is to choose a 
sufficiently long inversion time, allowing the feeding vessels to empty before acquisition [42, 43]. 
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Figure 3.9: Vascular architecture showing the different vessel types that could pass through a typical tissue volume [6].  
 
3.4.2.3. Inversion pulse shape and efficiency 
 
In PASL sequences, where a spatially well defined label is used, the shape of the inversion pulse is 
of great importance. Ideally, the profile should be truly rectangular, allowing zero spacing between 
the labelling slab and the imaging region. However, this is not realizable due to finite duration of the 
RF pulse [27]. The imperfect profiles can reduce labelling efficiency, and there can be contamination 
in the imaging region from the labelling slab. So, a gap between the inversion and imaging slab is 
often introduce to avoid those problems, but as a result, transit times increase. In order to minimize 
this gap, adiabatic pulses specially designed for this type of labelling are used such as (see Figure 
3.10): hyperbolic secant (HS), frequency offset corrected inversion (FOCI), or bandwidth-modulated 
adiabatic selective saturation and inversion (BASSI) [27]. 
For CASL approaches, the labelling is performed in general at a reasonable distance from the 
imaging slices, so the profile is less of a concern. 
 
 
Figure 3.10: A comparison of inversion profiles a hyperbolic secant (HS) pulse, a frequency offset corrected inversion (FOCI) 
pulse, and the rectangular ideal pulse (adapted from [27]).  
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3.4.2.4. Magnetisation transfer effects      
 
As mentioned earlier, the labelling pulse can cause substantial magnetisation transfer (MT) effects 
in the static tissue of the image slice, particularly with CASL due to the long labelling. It is important 
that the control image has the same MT effects so that they will cancel on subtraction. Any 
difference in MT effects will produce an additional non-perfusion signal in the difference image, 
leading to inaccurate quantification [27]. 
 
3.4.2.5. Signal to noise issues 
  
At normal perfusion rates (between 40 and 100 𝑚𝑙 100 𝑔−1 𝑚𝑖𝑛−1), the signal change ∆M is in 
the order 0.5 − 1.5% of the full signal [27]. Consequently, an average from typically 30 to 40 pairs of 
subtracted control and labelled images are required to get the desired SNR in the perfusion-weighted 
maps. A total scan time of 4 minutes is needed in order to acquire these data, which makes the 
technique very sensitive to motion artefacts. Proper head fixation and collaboration of the subject 
are necessary in order to obtain good results. 
Fast imaging techniques like single shot EPI or spiral sequences are often used to reduce the scan 
time between successive control-label pairs as well overall scan time. Furthermore, prior saturation 
of the image plane reduces the sensitivity to motion [27]. 
 
3.4.2.6. The role of blood equilibrium magnetisation 
 
The inflowing blood has a proton density different from the tissue. For absolute quantification, 
the equilibrium magnetisation of the arterial blood M0B  is needed, i. e., the available longitudinal 
magnetisation from a fully relaxed blood filled voxel. To achieve this parameter, a common approach 
is to measure the equilibrium magnetisation in a grey matter or white matter region and estimate 
M0B  using the blood-brain partition coefficient (𝜆) [44]. For single inversion time experiments, this is 
often done in a voxel by voxel basis using the control experiment as tissue magnetisation maps 𝑀0 
[27]. 
It is important to note that 𝑀0B  is a direct scaling factor of the perfusion (see Equation 3.8) and 
therefore an error in the estimation of it will directly change the calculated CBF value. 
 
3.4.3. Clinical and Research applications 
 
ASL techniques are unable to provide measurements of blood volume and mean tissue transit 
time, which could be of clinical use. However, they have been used in numerous applications, ranging 
from basic neuroscience using animal models and human volunteers to clinical perfusion 
measurement in pathologies such as stroke and brain tumours [28, 41, 45]. As long as the same 
procedure and parameters are consistently used, reproducible results can be achieved using ASL [4, 
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6]. Despite the problems related to the quantification of perfusion using ASL, most clinical decisions 
can be based on relative differences in CBF rather than absolute measures, which could render this 
method useful in the daily clinical practice.  
Although the majority of ASL perfusion research has been carried out in the brain, other organs 
including kidney [46] and lungs [47], have gained attention for measuring perfusion. Improved 
techniques and hardware available, in particular the move toward 3 T high field scanners in the 
standard clinical environments, seems to push this method from the research and development 
stage headed for clinical applications. 
  
3.5. Comparison between BOLD and ASL measurements 
 
BOLD contrast is the most commonly used fMRI method for studies of brain activity. However, 
there are some potential problems with the commonly applied technique in these applications. One 
of them is that the signal change can vary substantially between subjects and across sessions, for 
reasons that are poorly understood [23]. Moreover, the underlying physiological processes 
associated to BOLD signal changes, which includes a complex interaction of CBF, CBV and CMRO2, 
make changes in the BOLD signal difficult to interpret [24]. Direct CBF measurements using ASL had 
provided an attractive alternative. Because perfusion methods directly measure the amount of 
arterial blood that has been delivered to the capillary bed, the functional CBF signal may be more 
localised to the sites of neuronal activation than the BOLD signal, which derives primarily from blood 
oxygenation changes in the draining venules and veins proximal to the activated tissues [17, 24, 39]. 
A powerful feature of ASL techniques for fMRI is that they can be used to simultaneously acquire 
quantitative perfusion data and BOLD contrast data. If a sufficiently long TE is used for image 
acquisition, then BOLD contrast is present in the image series [27]. In fact, from a series of ASL 
images acquired with alternating control and labelling, perfusion and BOLD signals can be obtained 
by subtracting or adding the control and labelled images, respectively, in the same data sets. Recent 
studies have compared BOLD with CBF measurement using this non-optimised BOLD acquired 
simultaneously with the ASL technique. Such reports suggest that CBF measurement provides 
improved sensitivity relative to BOLD particularly for low-frequency tasks and is associated with 
lower inter-subject variability [39]. As a consequence, it has also been found that CBF measurements 
provide a more useful approach when assessing longitudinal activation changes [4].  
In conclusion, simultaneous acquisition of ASL and BOLD data provides several advantages for 
fMRI studies, including efficient acquisition of two functional images and minimization of temporal 
and spatial variations in the two signals. As ASL methods have become increasingly sophisticated, 
they have become increasingly useful in studies of brain-behaviour relationships in health and 
disease, ensuring a good complementary technique for BOLD contrast to measure neuronal activity 
during behavioural challenge tasks. In particular, the pre-surgical mapping of eloquent tissue can 
now be performed using combined ASL-BOLD techniques. 
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Chapter 4  
Materials and Methods 
 
4.1. Subjects 
 
Fifteen adult volunteers (six females, mean age 25.6, range 22-51 years) participated in this study. 
Participants were selected without regard to ethnicity or race or any other criteria. All subjects were 
right handed and none of them had a history of major medical, psychiatric or neurological disorders. 
The experiments were not carried out in the same day neither in the same period of the day, and 
with no control of subject’s state.  
This study was approved by the local ethical committee, and written informed consent was 
obtained from all volunteers. 
 
4.2. MR scanning 
 
Imaging was performed using a 3 Tesla Magnetom Verio MRI system from Siemens in Hospital da 
Luz Imaging Department. 
All subjects participated in a functional imaging session that involved one functional protocol for 
BOLD and two functional protocols for ASL, in which two different experiments were conducted: 
protocol #1 and protocol #2. The fMRI sessions included the acquisition of a high-resolution 
anatomical image using a 3D T1-weighted sequence (Magnetization Prepared Rapid Acquisition 
Gradient Echo, MP-RAGE), providing 160 sagittal slices with 1.0 mm of thickness, 256 x 240 mm2 field 
of view (FOV) and a matrix size of 256 x 240, yielding an isotropic spatial resolution of 1 mm3. Further 
scan parameters were: TR = 2250 ms, TE = 2.26 ms, an inversion time (TI) of 900 ms and a flip angle 
of 90°.  
It is important to report that the imaging sessions of some volunteers were split in two parts 
which were conducted in different days: a first part where the BOLD and the first ASL protocols were 
conducted and a second part where the second ASL protocol was performed. 
 
4.2.1. BOLD fMRI 
 
The BOLD protocol used a block design consisting on 4 cycles of 30 sec of rest (OFF) and 30 sec of 
motor task (ON), resulting in a total acquisition time of 240 sec (4 minutes). The motor activity 
consisted on a finger tapping task, by sequential thumb-digit opposition (as shown in Figure 4.1). 
FUNCTIONAL BRAIN PERFUSION EVALUATION WITH ASL AT 3 TESLA  
30 
Figure 4.1: Motor task performed by all volunteers: from left to right sequence of images illustrating the movement of the 
motor task. 
 
Functional images were acquired using a multi-slice single-shot gradient-echo (GRE) echo-planar 
imaging (EPI) sequence. The whole brain was covered with 37 contiguous axial slices of 3 mm 
thickness, positioned parallel to the anterior-posterior commissure (AC-PC), as shown in Figure 4.2 
a). Eighty dynamic volumes were collected for each functional scan. The other imaging parameters 
were as follows: TR = 3 sec, TE = 30 ms, flip angle = 90°, FOV = 256 x 256 mm2 and a matrix size of 64 
x 64, yielding a resolution of 4 x 4 x 3 mm3. The slice acquisition order was ascending, interleaved. 
The sequence has been driven in 3D PACE mode (Siemens Erlangen) enabling prospective motion 
correction. 
Prior to the functional scanning, a B0 field map was acquired for the same slice prescription as the 
one to be used for the BOLD acquisition. The field maps are based on gradient echo sequences and 
allow the measurement of the main magnetic field (B0 field). They can then be used to explain the 
susceptibility artefacts observed in EPI, namely geometric distortions and signal loss. The former can 
at least partially be corrected for. The latter can only be indicated, to allow more accurate 
interpretation of the results. 
It is important to refer that this BOLD protocol is the one used in clinical applications at Hospital 
da Luz, which has been used extensively by neuroradiologists with satisfactory results. 
 
4.2.2. ASL fMRI 
 
The ASL application package commercially available by Siemens consists of a sequence with 
pulsed arterial spin labelling for perfusion-weighted imaging. This sequence comprehends three 
different labelling schemes: 
1. PICORE Q2TIPS using FOCI pulses; 
2. FAIR QUIPSS II using HS pulses; 
3. PICORE QUIPSS II using BASSI pulses. 
 
                                     
Figure 4.2: Illustration of a typical prescription of the imaging slab positions for a) BOLD and b) ASL experiments, from 
sagittal scout scan.  
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Figure 4.3: Pulse sequence used for Q2TIPS ASL imaging. On the right the locations of the in-plane pre-saturation slab, 
imaging slice(s), periodic saturation slice, and inversion slab used in the PICORE labelling scheme are shown [38].   
 
The method used in this work was the scheme 1 and it has been described by Luh et al. [38], and 
is illustrated in Figure 4.3. In this method two 90 RF pulses (sinc modulation, 25 ms duration) are 
applied to pre-saturate the imaging region. Next, a 180 inversion pulse (FOCI modulation) is applied 
to label the arterial spins over a 10cm thick labelling region. The first inversion time 𝑇𝐼1 allows the 
inverted arterial spins to flow to the imaging slab. Between 𝑇𝐼1 and 𝑇𝐼1𝑠 (𝑇𝐼1 stop time) 90 
saturation pulses (sinc modulation, 20 ms duration) are repeatedly applied over a 20 mm thick 
saturation slab, in order to define the time width of the bolus. Image acquisition is carried out at 𝑇𝐼2 
using a GRE-EPI readout module. In the control measurement, the inversion pulse is applied off-
resonance, with a symmetrical frequency relative to the imaging region, such that that no inversion 
occurs in the labelling slab but the same off-resonance effects are present in the imaging slices. The 
off-resonance effects should therefore be cancelled out on the difference image between control 
and tag. 
Two different protocols for functional studies with ASL have been conducted. The parameters of 
both experiments are described next. 
 
4.2.2.1. ASL protocol #1 
 
This primary ASL protocol consisted on the acquisition of one perfusion scan during rest and 
another one during an equal period of motor activation, resulting in a total acquisition of 
approximately 8 minutes. A total of 91 interleaved tag and control volumes were acquired (for each 
perfusion scan). The PASL parameters were as follows: TI1 = 700 ms, TI1s = 1600 ms, TI2 = 1800 ms, 
TR/TE = 2500/11 ms and flip angle = 90°. The imaging region consisted of 9 contiguous axial slices of 
8 mm thickness positioned parallel to the AC-PC axis, between the vertex of the brain to the top of 
cerebellum (as shown in Figure 4.2 b)). The imaging slab had a FOV = 256 x 256 mm2 and a matrix size 
of 64 x 64, yielding a resolution of 4 x 4 x 8 mm3, and the gap between the labelling slab and the 
proximal slice was 18.8 mm. The slices were acquired in ascending order. 
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The sequence was also been driven in 3D PACE mode (Siemens, Erlangen) enabling prospective 
motion correction. 
 
4.2.2.2. ASL protocol #2 
 
For functional studies, the previous protocol was changed to a new protocol, where not only the 
functional paradigm was modified, but also some acquisition parameters were optimized. This new 
experiment consisted on a blocked design with 5 cycles of OFF blocks (25 sec each) alternated with 5 
ON blocks (25 sec each). A total of 101 volumes alternating between tag and control were acquired, 
resulting in a total scan of 4 min 12.5 sec. 
In order to find the optimal TE value for ASL functional measurements, a pilot test was performed 
using three different TE values: 11 ms, 20 ms and 30 ms. The value TE = 11 ms was chosen, because it 
optimized the ASL functional changes, while still allowing for simultaneous BOLD contrast in the 
same scan. The parameters chosen for ASL functional protocol #2 were the same as protocol #1, 
except for: TR/TE = 2500/11 ms, 9 contiguous axial slices of 6 mm thickness parallel to the AC-PC line 
(the imaging slab was positioned as shown in Figure 4.2 b), with a FOV = 224 x 224 mm2 yielding a 
resolution of 3.5 x 3.5 x 6 mm3.  
Prior to the functional scanning, a field map with the same slice prescription as the one used for 
the PASL scan was acquired. 
 
Functional data acquisition parameters for the three protocols described early are resumed in 
Table 4.1. 
 
Table 4.1 
Functional data acquisition parameters 
  EPI readout Tagging Sequence: PICORE Q2TIPS   
Prot. 
TR       
(ms) 
TE     
(ms) 
FA 
No. 
vols. 
No. 
slices 
Slice 
thick 
(mm) 
Matrix 
size 
FOV             
(mm
2
) 
TI1       
(ms) 
TI1s    
(ms) 
TI2     
(ms) 
Inv. slab 
thicknes 
Gap 
(cm) 
Taq.  
(min) 
BOLD 3000 30 90° 80 37 3 64 x 64 256 x 256 ----- ----- ----- ----- ----- 4:00 
ASL 
#1 
2500 25 90° 91+91 9 8 64 x 64 256 x 256 700 1600 1800 1 cm 1.88 7:35 
ASL 
#2 
2500 11 90° 101 9 6 64 x 64 224 x 224 700 1600 1800 1 cm 1.88 4:13 
 
4.3. Image analysis 
 
Image processing and analysis were carried out with Siemens Syngo MR software (task cards 
Viewer, 3D and Neuro 3D), a software from the Oxford University Centre for Functional MRI of the 
brain (FMRIB) called FSL (FMRIB’s Software Library) [48], and self-written MATLAB (The Mathworks, 
Natick, MA, USA) and Linux shell script routines. 
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Syngo Neuro 3D is a highly intuitive user interface software that simplifies and improve workflows 
in clinical routine. Statistical analysis of the functional data is performed by fitting a general linear 
model (GLM) to the BOLD data. The final result of this analysis is a t-map called “Eva-Series – GLM” 
that contains the activation clusters: its lower and upper limits can be tailored manually with the 
Neuro 3D task card.  
FSL is a powerful software that includes a comprehensive library of analysis tools for fMRI, MRI 
and DTI brain imaging data [49]. Some of these tools can be run both from the command line and as 
graphical user interfaces (GUI). For functional data analysis, the fMRI Expert Analysis Tool (FEAT) was 
used. FEAT is part of FSL and has a complete toolbox for high quality fMRI data analysis. This 
software tool carries out data preprocessing, including slice timing correction, motion correction with 
MCFLIRT (Motion Correction FMRIB’s Linear Image Registration Tool) and fieldmap-based EPI-
distortion correction with FUGUE (FMRIB's Utility for Geometrically Unwarping EPIs). The data 
modeling which FEAT uses is based on the GLM. It allows the description of the experimental design 
and then a model is created that should fit the data showing where the brain has activated in 
response to the stimuli. The GLM is then fitted to the time-series data using FILM (FMRIB's Improved 
Linear Model), a robust and accurate nonparametric estimation algorithm, with autocorrelation 
correction by prewhitening; this gives improved estimation efficiency compared with methods that 
do not prewhiten. The following tools from FSL have also been used: BET (Brain Extraction Tool) to 
delete non-brain tissue from an image of the whole head, FAST (FMRIB’s Automated Segmentation 
Tool) to perform segmentation of the brain into different tissue types (grey matter, white matter and 
CSF), FLIRT (FMRIB’s Linear Image Registration Tool) to perform linear image registration, and FSL 
View to display 3D and 4D data and prescribe imaging ROI’s. Furthermore, a set of useful command-
line utilities called FSLUTILS has also been used to allow the conversion and manipulation of the 
images [25, 49]. 
It is important to note that Syngo MR works with DICOM (Digital Imaging and Communications in 
Medicine) format images, and that FSL uses NIfTI-1 (Neuroimaging Informatics Technology Initiative) 
data format by default. For that matter, MRIConvert has been used to perform the conversion from 
DICOM to NIfTI FSL format. 
 
4.3.1. Field map-based EPI distortion correction 
 
It is possible to measure the field inhomogeneities across an imaging scan with a fieldmap 
sequence. These measured field values can be used to calculate the geometric distortion and signal 
loss, and then to use the calculate information to compensate for these artifacts. The aim of this 
approach was to compare the main applications of both FSL and Neuro 3D task card Syngo software 
with the field map image.  
The Syngo software simply loads the fieldmap and overlays it to the functional t-map: the user is 
then able to identify regions of severe susceptibility /strong B0 inhomegeneity) artifacts and can 
chose to ignore the results obtained in those regions. The threshold for the region exclusion based 
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on the severity of the artifacts can be adjusted manually by the user, according to how strict the 
analysis should be. 
In FSL, the fieldmap is further used to actually correct the geometric distortions present in the EPI 
data due to the susceptibility artifacts. A GUI interface exists for applying FUGUE as part of the FEAT 
pre-processing options (see Figure 4.4). This implementation of FUGUE uses a measured field map to 
unwarp distorted images by performing pixel shifts in the phase-encode direction. In the GUI, the 
two images that are required are: a real fieldmap image which must have units of rad/s, and a brain-
extracted and registered magnitude image. Next it also needs the Effective EPI echo spacing (in ms), 
which is the time between echoes in successive k-space lines, the EPI echo time (also in ms), and the 
Unwarp direction, which is the phase-encoding direction of fMRI EPI data. To further understand 
what kind of processing has been done here is important to know how these fieldmap images are 
acquired. Unfortunately, there is no standard sequence for fieldmap acquisitions and different 
scanners return different images. The most common sequences acquire two images with different 
echo times. The change in MR phase from one image to the other is proportional to both the field 
inhomogeneity in that voxel and the echo time difference. The field value is therefore given by the 
difference in phase between these two images divided by the echo time difference. As the phase is of 
great importance in fieldmaping, but is normally not saved in other sequences, these images are 
often quite different from the standard images.  
 
 
Figure 4.4: Layout of GUI interface for FUGUE (part of FEAT), for applying EPI distortion correction. 
 
Since each scanner can give different data, the first step in practice was to find what kind of 
fieldmap acquisition data the scanner gives. Using fslinfo and consulting the DICOM header of these 
images, it was determined that the type of the fieldmap images was one single image: the result of 
the subtraction between phase images. So this image hadn’t been reconstructed fully into a fieldmap 
yet. For that, it was necessary to follow some pre-processing steps. As we only have the subtracted 
phase image, we needed to get a magnitude image that is undistorted and registered with this phase 
image. This has been made registering the brain extracted from the structural image from the high 
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resolution space to the fieldmap space based in their qforms and sforms (those matrixes give the 
locations of the voxels centers in the (𝑥,𝑦, 𝑧) coordinate system). After we check that the magnitude 
image and the subtracted phase image have the same resolution, we convert the phase image to 
radians, tapping the follow command: 
 
          fslmaths phase_image –mul 3.14159 –div 2048 phase_rad –odt float                                              g                     
 
The value 2048 is the maximum intensity in the integer format of the raw images. Then we used 
PRELUDE (Phase Region Expanding Labeller for Unwrapping Discrete Estimates) to do the required 
phase unwrapping: 
 
          prelude –a fieldmap_mag –p phase_rad –o phase_unwrap_rad                                                        g 
 
Finally, to get the real fieldmap in rad/s we did: 
 
          fslmaths phase_unwrap –mul 1000 –div TE fieldmap_rads –odt float                                               g 
 
where TE was replaced with the appropriate difference in echo times. In this case TE = 7.38 ms. The 
Effective EPI echo spacing used was 0.7 ms, and the phase-encoding direction (unwarp direction) 
selected was −𝑦 .  
This approach was performed for all subject’s data for BOLD protocol and ASL functional protocol 
#2 (since in ASL protocol #1 it hadn’t been acquired a fieldmap image). 
 
4.3.2. Functional data 
 
Analysis of functional data was carried out with both FSL and Neuro 3D task card Syngo software. 
This latter automatically produces a t-map using a GLM approach, based on the indication by the 
user of the baseline and activation periods throughout the experiment. However, during this study, 
this GLM approach couldn’t be applied for ASL functional data, because the functional analysis utility 
was disabled for the ASL sequence. In terms of perfusion analysis, the Neuro 3D task card Syngo 
software performed the pairwise control/tag subtraction and subsequent perfusion calculation. The 
output is therefore a perfusion weighted map (arbitrary units) and a quantitative relCBF map 
(ml/min/100ml). For the first protocol, we have two quantitative relCBF maps: one corresponds to 
the rest state, and the other corresponds to the motor activation. The difference between these two 
maps was computed, and then fused with BOLD information in order to achieve a better comparison 
between both results. The steps for this procedure involved not only Neuro 3D task card, but also the 
Viewer and 3D task cards within Syngo software, and are resumed in Appendix A A.1. 
In FSL, analysis of functional data was performed using FEAT Version 5.98 [25]. For these analyses, 
motion corrected (PACE) time-series were used. The following pre-statistics processing steps were 
applied to all datasets: non-brain removal using BET, spatial smoothing using a Gaussian kernel of full 
width at half maximum (FWHM) 5 mm, and high-pass temporal filtering (σ = 20 sec). Time-series 
statistical analysis was performed using FILM with local autocorrelation correction. The definition of 
the stimulus conditions in this tool was different for the three functional protocols. 
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For the BOLD protocol, one stimulus condition was defined, using one EV (explanatory variable), 
according to the stimulation paradigm applied, i.e., 30 s OFF and 30 s ON. This block pattern was 
convolved with a gamma function with Stddev of 3 s and mean lag of 6 s (default values), which 
models the hemodynamic response function (HRF) (see Figure 4.5). 
For ASL protocol #2 the data needed specific processing because each voxel’s time-series 
alternates between “tag” and “control” conditions. So, 3 EV’s were setup: EV1 to model the 
alternation between control and tag conditions, EV2 to model the alternation between periods of 
activation and rest, similar to the one described for BOLD protocol, and EV3 is the interaction 
between EVs 1 and 2, to model the activation component of the control-tag signal (see Figure 4.5). 
This last explanatory variable reflects the expected response from an ASL functional study. In 
summary, the EV1 was defined with a pattern of 2.5 s OFF and 2.5 s ON, since the TR of the 
acquisition sequence was 2.5 s. The EV2 was defined according to the stimulation paradigm applied: 
25 s OFF and 25 s ON. This pattern of 25 s ON and 25 s OFF was convolved with a gamma function 
with Stddev of 3 s and mean lag of 6 s (similar to the BOLD analysis). Finally, the EV3 was simply 
defined by the interaction between the last two EVs (which can be made automatically by FEAT). For 
this approach, it’s important to note that the tag-control order of the data must be known. 
 
 
Figure 4.5: Design matrixes for the three functional protocols performed with FEAT. For each EV of each protocol, two 
contrasts were considered (C1 and C2, C3 and C4, and C5 and C6) where one is the symmetric of the other. In practice, only 
the first contrast of each EV has been considered.   
 
In order to analyse the data from ASL protocol #1 using a similar approach in FSL, we had to 
concatenate the rest and activation scans, in order to have one single time-series data. We 
eliminated the first volume of each time-series, so that this procedure results in one single time-
series dataset with 180 volumes, which the first 90 volumes corresponding to the rest state and the 
other 90 volumes corresponding to the activation state. Then we were able to define the 3 EV’s. EV1 
and EV3 were equally defined. EV2 was defined with 225 s OFF and 225 s ON pattern, convolved with 
a gamma function with the same parameters defined for the other two protocols (see Figure 4.5). 
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By fitting of the GLM to the data, the parameter estimates (PE) corresponding to each EV are 
determined and the pre-defined contrasts (COPE) are computed. A t test is then applied to each 
COPE, resulting in a Z (Gaussianised T/F) statistic map for each contrast. The Z maps were 
thresholded using a clustering procedure, whereby each cluster is determined by a voxel 𝑍 > 2.5 and 
a (correct) cluster significance threshold of 𝑃 = 0.05 for all data sets. 
For BOLD data, registration of the functional images to the corresponding individual high-
resolution T1-weighted structural images and the MNI (Montreal Neurological Institute) standard 
brain was carried out using FLIRT with 7 and 12 degrees of freedom (DOF), respectively. For ASL 
functional data, we first registered the functional images to an equivalent EPI image but covering the 
whole-brain (acquired during the same session from the subject), using FLIRT 3 DOF, before further 
transformation to the high-resolution T1-weighted structural and MNI standard brain. 
 
4.3.3. Segmentation of structural data 
 
The segmentation was performed using the FAST tool, part of FSL [25]. To do this, first we 
registered the 𝑇1 high resolution image to the perfusion images using FLIRT, in order to have a 
structural image with higher definition and without signal distortion and loss in ASL space. Then, 
FAST was used to segment this structural image of each subject into grey matter (GM), white matter 
(WM) and CSF. The output images created for each subject were: a partial volume map, which is a 
non-binary partial volume image for each class, where each voxel contains a value in the range of 0-1 
that represents the proportion of that class’s tissue present in that voxel, and a binary segmentation 
image per class. These images were needed for CBF quantification, and were also used in the 
subsequent computation of CBF analysis and in obtaining subject specific masks. 
 
4.4. Data analysis 
 
The data analysis consisted in approaches developed for specific tests in order to evaluate the 
results given from each functional protocol, to look at some abilities of ASL protocols and to explore 
some properties of ASL data analyses in FSL. The statistical analyses were performed by means of the 
MATLAB software and the Statistical Package for the Social Sciences (SPSS) Version 17.0. For all 
statistical tests described below, significance was accepted if  𝑝 < 0.05.  
 
4.4.1. Variability and Localisation of motor activation 
 
To define the location of motor activation, only BOLD protocol (currently used in clinical 
applications) and ASL functional protocol #2 have been considered. This study was performed to 
evaluate the extent of motor activation areas given by the two experiments. Although the TE is short 
and not optimized for BOLD contrast in ASL protocol #2 (TE = 11 ms), this contrast was additionally 
used in this study for the comparison between both protocols. It provides an additional measure 
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within the same setup. In summary, we are comparing here two protocols by means of three 
different approaches:  
- BOLD: the BOLD contrast from BOLD protocol; 
- BOLDASL: the BOLD contrast from ASL protocol #2; 
- CBF: functional CBF contrast from ASL protocol #2.  
The activation clusters given by each experiment of each subject were registered to the MNI 
standard brain using FLIRT from FSL to perform an inter-subject comparison and a group analysis. For 
calculation of the location of activation, it has been proposed using the cluster’s centre of gravity 
(COG) measurement technique which is the weighted (by signal change) location of the centre of 
activation within a cluster volume of neighbouring voxels that are significantly activated.  
To test if BOLD, BOLDASL and CBF activation areas co-localise, the displacement of the location of 
activation from BOLD, BOLDASL and CBF in each subject was calculated in terms of the Euclidean 
distance between the Cartesian coordinates (𝑥,𝑦, 𝑧) from the COG measurement within the MNI 
standard space. The mean displacement across the group was calculated for each experiment. The 
hand primary motor cortex (HMC) of left hemisphere was used as reference to measure the relative 
displacement and distance for each experiment. For the localisation of HMC, the knob-like structure 
of the precentral gyrus that most often contain a motor hand function was considered [10]. This 
segment is shaped like an omega in the axial plane and like a hook in the sagittal plane. Nine points 
(three medial points M1, M2 and M3, three lateral points L1, L2 and L3, and three central points CM, 
CL and CC) under the omega shaped segment of MNI standard brain were drawn by a 
neuroradiologist, and two mean points were calculated: C1 which is the mean point of the three 
central points, and C2 which is the mean point of all nine points (as shown in Figure 4.6). The 
rationale of this approach was to determine which BOLD, BOLDASL or CBF activations is closer to HMC. 
The displacement with respect to the HMC and the Euclidean distance were calculated for each 
subject for each experiment. Euclidean distance between generic points A and B was defined as: 
 
𝐷𝐴−𝐵 =   𝑥𝐴 − 𝑥𝐵 
2 +  𝑦𝐴 − 𝑦𝐵 
2 +  𝑧𝐴 − 𝑧𝐵 
2    Equation 4.1 
 
where 𝑥𝑖 , 𝑦𝑖   and 𝑧𝑖  are the coordinates of point 𝑖. The group mean Euclidean distance between 
BOLD, BOLDASL and CBF activation was compared using an Analysis of Variance (ANOVA). 
 
 
Figure 4.6: Localisation of the hand primary motor cortex: 3 medial points     (M3, M2 and M1), 3 lateral points    (L1, L2, L3), 
3 central points      (CC, CM and CL), and two mean points      (C1 and C2). 
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To compare the inter-subject extent of activation areas, for each experiment and for each 
coordinate, the variance of activation COGs between all subjects was calculated (𝑉𝑎𝑟 =   𝑥𝑖 −
𝑥𝑎𝑣𝑔  
2/(𝑁 − 1), with 𝑁 = 15 𝑠𝑢𝑏𝑗𝑒𝑐𝑡𝑠). In addition, three inter-subject activation maps were 
computed: for each experiment the COGs and the local maxima location of the activation clusters of 
all subjects were displayed in order to illustrate the common area of overlap and to qualitatively 
compare the extent of activation between BOLD, BOLDASL and CBF. 
 
4.4.2. CBF quantification methods 
 
In the Q2TIPS PASL sequence used in this work, as previous mentioned, bolus width 𝑇𝐼1 is well 
defined and can be set by the user. The ASL difference signal between labelled and control images 
(∆𝑀) can then be made minimally sensitive to the transit delay 𝛿𝑡 by setting the image acquisition 
time  𝑇𝐼2 ≥ 𝑇𝐼1 + 𝛿𝑡. In this case, quantitative perfusion maps can be obtained by computing the 
CBF in each pixel using the equation [39]: 
 
𝐶𝐵𝐹 =
𝜆∆𝑀
2𝛼𝑀0𝑇𝐼1𝑒
−𝑇𝐼2/𝑇1𝑏
       Equation 4.2 
 
Table 4.2 displays the values used for perfusion quantification parameters.  
 
Table 4.2  
Perfusion quantification parameters used to calculate CBF (α, λ and 𝑇1𝑏  were consulted in [27, 50]) 
𝜶 λ 𝑻𝑰𝟏 𝑻𝑰𝟐 𝑻𝟏𝒃 
90 % 0.9 ml/g 700 ms 1800 ms 1500 ms 
 
The equilibrium magnetization of the tissue,𝑀0, was determined considering the average of the 
control volumes from each subject ASL data sets. The averaged image was then masked with the GM 
binary mask from FAST (obviously registered to ASL space). To account for the slice acquisition 
ordering effects and to avoid introducing noise in the perfusion maps, we calculate the signal mean 
for each slice, i.e., for each slice of a specific volume there is a single mean value. 
For this single TI quantification, three different approaches were explored in order to obtain more 
accurate CBF values and study the variances between the values given by each approach:  
 
- Method 1: In this method we applied Equation 4.2, with the values expressed in Table 4.2 
for the whole volume. 
 
-Method 2: In this second method we applied Equation 4.2, with the values expressed in 
Table 4.2 for the whole volume, but with correction of slice readout timing, 𝑇𝐼2. The slices of a 
specific volume are not acquired simultaneously, i.e., the first slice is acquired in a certain 
time  𝑡1, but the second slice is acquired in a time 𝑡1 + ∆𝑡 (since the slice acquisition is 
performed in the ascending order). This causes a error in the estimation of perfusion, which is 
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especially significant for the upper slices. So, we use the information of slice acquisition time 
(from the DICOM header) to correct this slice acquisition timing effect. 
 
- Method 3: In this last method we used the same equation but with the correction factor𝑞𝑝 : 
 
𝐶𝐵𝐹 =
𝜆∆𝑀
2𝛼𝑀0𝑇𝐼1qp 𝑒
−𝑇𝐼2/𝑇1𝑏
       Equation 4.3 
 
𝑞𝑝  is the correction factor that accounts for the difference between the T1 of blood and the T1 
of brain tissue [36], and is expressed by: 
 
𝑞𝑝 =
𝑒𝑘𝑡  𝑒−𝑘𝛿𝑡 −𝑒−𝑘(𝜏+𝛿𝑡 ) 
𝑘(𝑡−𝛿𝑡)
       
with 
 
𝑘 =
1
𝑇1𝑏
−
1
𝑇1
′           𝑎𝑛𝑑       
1
𝑇1
′ =
1
𝑇1
+
𝑓
𝜆
  
 
To apply Equation 4.3 we had to do several approaches. Since this is a non-linear equation we 
approximated 1/𝑇1′ = 1/𝑇1 + 𝑓/𝜆 to 1/𝑇1′ ≈ 1/𝑇1. A typical human CBF of 60 𝑚𝑙/100𝑔/𝑚𝑖𝑛 
corresponds to 𝑓 = 0.01 𝑠−1, and with 𝜆 = 0.9 and 𝑇1 of approximately 1 s, the difference 
between 𝑇1′ and 𝑇1 is only approximately 1%. That’s the error that we are committing in this 
approximation. The transit time 𝛿𝑡 could be calculated experimentally as mentioned before, 
but not with this sequence/protocol. So, we had to estimate this parameter. Wong et al. [17] 
have determined experimentally that this transit delay ranges from about 500 − 1500 ms for 
a physical gap of 1 − 3 cm between the tag region and the imaging slice. Then, the linear 
relation 𝛿𝑡 𝑧 = 500𝑧 was assumed. This expression allows estimating the transit time 𝛿𝑡 (in 
ms) at a slice distance z from the tag region (in cm), and reflects that the transit delay of blood 
is 500 𝑚𝑠 per cm of distance travelled. In this approach we also used the information of slice 
acquisition time (from the DICOM header) to correct the slice acquisition timing effect. The 
value of 𝑇1 used was 1200 ms [50].  
 
In order to detect statistically significant differences between CBF values provided by each 
approach, t-tests were performed. To allow a more complete comparison between them, the mean 
value of each slice for all volumes was calculated from each of the three maps obtained.  
To generate the quantitative perfusion maps by these three methods, a shell script routine in 
Linux with some FSL command utilities has been developed (see Appendix A A.2).  
 
4.4.3. CBF quantification in Rest and Activation conditions 
 
The difference on CBF values between the condition of rest and the condition of activation was 
assessed using both ASL functional protocols. For ASL protocol #1, quantitative perfusion maps for 
rest and activation were easily performed, since we had two different images corresponding to both 
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conditions. For ASL protocol #2, first we had to concatenate the images of the 5 blocks in rest and 
images of the 5 five blocks in activation, in order to produce also two quantitative maps for both 
conditions.   
For each subject and for each protocol, the respective CBF activation clusters given by statistical 
analysis were used to mask the respective quantitative maps, and the mean value within the cluster 
was calculated. The difference between CBF of activation (𝐶𝐵𝐹𝑎𝑐𝑡 ) and CBF of rest (𝐶𝐵𝐹𝑟𝑒𝑠𝑡 ) in 
absolute unities (𝑚𝑙/100𝑔/𝑚𝑖𝑛) was computed: 
 
∆𝐶𝐵𝐹 = 𝐶𝐵𝐹𝑎𝑐𝑡 − 𝐶𝐵𝐹𝑟𝑒𝑠𝑡       Equation 4.4 
 
Moreover, the relative variation between 𝐶𝐵𝐹𝑎𝑐𝑡  and 𝐶𝐵𝐹𝑟𝑒𝑠𝑡  in percentage was also calculated: 
  
%∆𝐶𝐵𝐹 =
𝐶𝐵𝐹𝑎𝑐𝑡 −𝐶𝐵𝐹𝑟𝑒𝑠𝑡
𝐶𝐵𝐹𝑟𝑒𝑠𝑡
× 100      Equation 4.5 
 
4.4.4. SNR of perfusion-weighted images 
 
The resultant perfusion-weighted images from the ASL difference signal between labelled and 
control images (∆𝑀) were used for the estimation of SNR in both GM and WM. For SNR estimates, 
two ROIs (one per tissue type) with 25 pixels were manually prescribed in the perfusion maps (see 
Figure 4.7 a) and Figure 4.7  b)) by using the segmented GM and WM masks from FAST as guides. 
Their mean signal intensity was calculated. Noise was computed as the SD in a 25 pixels ROI placed 
outside the head in the upper right corner of the image (see Figure 4.7 c)). The mean perfusion SNR 
was then calculated for both GM and WM. A t test analysis was then performed to assess for 
significant differences between the mean GM perfusion SNR and the mean WM perfusion SNR.  
SNR was computed for PW images of ASL protocol #1 and ASL protocol #2. 
 
 
Figure 4.7: Manually prescribed example ROIs for GM and WM SNR estimation: a) GM signal ROI, b) WM signal ROI and c) 
noise ROI. 
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4.4.5. CBF quantification: effect of anterior and posterior circulation 
 
For the analysis of both anterior and posterior circulation effects, we consider the quantitative 
perfusion maps in rest of ASL protocol #1 obtained with Method 2. Two regions of interest (ROIs) 
were selected in each subject. Both ROIs were drawn by hand on the perfusion-weighted maps to 
select one frontal brain region (ROI 1) and one occipital region (ROI 2). To keep the ROIs equal in size 
across subjects, both ROIs drawn have 30 voxels each. The mean values of CBF in each ROI were 
compared. 
 
4.4.6. CBF quantification in GM and WM 
 
To assess the difference between CBF values of GM and WM, we also consider the quantitative 
perfusion maps in rest of ASL protocol #1 obtained with Method 2. Each subject’s perfusion map was 
masked with the binary masks of GM and WM obtained from FAST. The mean value has been 
calculated. 
 
4.4.6.1. Partial volume effect 
 
One of the two outputs of the segmentation procedure is a partial volume map for each tissue 
type. It means that for each tissue type, there is a non-binary partial volume image where each voxel 
contains a value in the range of 0-1 that represents the proportion of that tissue type present in that 
voxel. These non-binary maps (called  𝑝𝑣𝑒_𝑚𝑎𝑝𝑠) were used in order to correct the partial volume 
effect in the perfusion measurements. For this, the rationale was that the mean value of perfusion in 
the GM binary mask is equal to the true GM perfusion multiplied by the GM fraction in the mask, i.e., 
the mean of the GM 𝑝𝑣𝑒_𝑚𝑎𝑝 in the GM binary mask, added to the true WM perfusion multiplied by 
the WM fraction in the mask, i.e., the mean of the WM 𝑝𝑣𝑒_𝑚𝑎𝑝 in the GM binary mask. Following 
the same logic for the mean perfusion in the WM mask, we reached two expressions: 
 
 
 𝑓 𝐺𝑀𝑚𝑎𝑠𝑘 =  𝑝𝑣𝑒𝐺𝑀  𝐺𝑀𝑚𝑎𝑠𝑘 𝑓𝐺𝑀 +  𝑝𝑣𝑒𝑊𝑀 𝐺𝑀𝑚𝑎𝑠𝑘 𝑓𝑊𝑀
 𝑓 𝑊𝑀𝑚𝑎𝑠𝑘 =  𝑝𝑣𝑒𝐺𝑀  𝑊𝑀𝑚𝑎𝑠𝑘 𝑓𝐺𝑀 +  𝑝𝑣𝑒𝑊𝑀 𝑊𝑀𝑚𝑎𝑠𝑘 𝑓𝑊𝑀
   Equation 4.6 
 
where  𝑓 𝐺𝑀𝑚𝑎𝑠𝑘  and  𝑓 𝑊𝑀𝑚𝑎𝑠𝑘  are the mean values of CBF in GM and WM binary masks, and 
 𝑝𝑣𝑒𝐺𝑀 𝐺𝑀𝑚𝑎𝑠𝑘 ,  𝑝𝑣𝑒𝑊𝑀 𝐺𝑀𝑚𝑎𝑠𝑘 ,  𝑝𝑣𝑒𝐺𝑀 𝑊𝑀𝑚𝑎𝑠𝑘   𝑝𝑣𝑒𝑊𝑀 𝑊𝑀𝑚𝑎𝑠𝑘  are the mean values of the 
GM and WM 𝑝𝑣𝑒_𝑚𝑎𝑝𝑠 in GM and WM binary masks, and 𝑓𝐺𝑀  and 𝑓𝑊𝑀  are the true CBF values of 
the GM and WM respectively.  
These two equations were then solved in order to determine 𝑓𝐺𝑀  and 𝑓𝑊𝑀  for each subject and 
compare with the previous values achieved. 
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Chapter 5  
Results and Discussion  
 
In this chapter, the results of the image pre-processing, post-processing and data analysis are 
shown, explained and discussed. Considering the images presentation, it’s important to report that 
only the images from one of the 15 subjects are presented in order to illustrate the results. The 
functional images of all subjects can be seen in Appendix A A.3. 
 
5.1. EPI distortion correction 
 
With Neuro 3D task card Syngo software, the field map is automatically co-registered to the 
subject’s structural anatomic space and is overlaid on to the structural anatomic image. Figure 5.1 
shows a representative EPI image acquired for BOLD experiment and the resulting field map given by 
Neuro 3D. 
 
 
Figure 5.1: Field map image given by Neuro 3D from subject 4. Seven axial slices of the structural image (on the top) and the 
respective regions of severe field inhomogeneity obtained from the field map (on the middle) are represented. On the 
bottom is represented the overlay of the field map upon the structural image. 
 
In the images of Figure 5.1 we can see the regions of severe field inhomogeneity obtained from 
the field map, represented in pink, which are co-registered to the structural space and displayed over 
the structural image. This pink map points out the regions where local distortion and signal loss of 
functional images occur, due to the main magnetic field inhomogeneities and the sensitivity of the 
EPI measurement technique to these.  
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With FSL we used the fieldmap image given by the scanner without any treatment by Neuro 3D. 
Figure 5.2 shows a typical fieldmap image from the scanner of one subject. 
 
 
Figure 5.2: Phase difference image given by the scanner from subject 4. Seven representative axial slices are represented. 
 
Although the image appears to be useless, it contains the relevant information about the phase 
changes, which are proportional to field inhomogeneity and echo time difference. The image 
obtained after we performed the pre-processing needed to achieve a real field map (application of 
PRELUDE and conversion to rad/s) is shown in Figure 5.3. 
 
 
Figure 5.3: Field map obtained with FSL. 5 representative slices from subject 7 are represented: the phase difference image 
(on top), the unwrapped field map image (on the middle), and the magnitude image (on the bottom). 
 
The two bottom images were the two used in FEAT: the first is the field map image (in rad/s) and 
the second is the magnitude image. As we can see, image quality improved a good bit. 
Like the pink map displayed by Syngo Neuro 3D task card, in the field map achieved the signal is 
more intense in the inferior temporal and frontal lobes, which means those are the main regions 
where the functional image’s artifacts are more noticeable. These regions don’t include the primary 
sensory motor region. Then, in this study the functional results don’t suffer from artefacts caused by 
the main field inhomogeneities. By the graph of Figure 5.4 we can fully grasp the field map 
differences between the frontal lobe region and the other brain regions. 
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Figure 5.4: 3D representation of one slice of the unwrapped field map. Slice location is showed on top left sagittal slice. The 
major phase difference (in rads) is clearly shown in the frontal and temporal region of the brain.  
 
In Figure 5.5, the original distorted EPI are compared with the undistorted EPI after FUGUE.  
 
 
 
Figure 5.5: Distorted and undistorted EPI images of functional data. On the left we have three different views/plans of the 
distorted (original) EPI, and on the right we have the same three different views of the undistorted (after FUGUE) EPI.  
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In Figure 5.5, orange squares point out the areas where differences between the corrected and 
uncorrected images are more pronounced. In the right images, we can observe some improvements 
in the EPI images. Although the signal loss (intensity) wasn’t restored, local geometric distortion 
presented in the original EPI was corrected. Moreover, we used both EPI distorted and undistorted 
images in registration procedures. And the distortions of the original EPI images lead to more global 
errors in registration than undistorted EPI images.  
Distortion of EPI-based functional images is a particular problem for high-field (3T and higher) MR 
scanners. The inhomogeneities in the magnetic field caused by susceptibility differences at air–tissue 
interfaces (predominantly near air-filled sinuses) result in both signal loss and geometric distortion of 
images. As we saw, such artefacts are particularly noticeable in the inferior temporal and frontal 
lobes, and restrict the use of standard fMRI techniques in these areas. In addition, the distortions can 
also lead to global errors in registration, if not accounted for, causing errors in the spatial localisation 
of activations from any brain region, including those where there is little or no distortion present. 
Then the acquisition of this field map is very important in clinical applications. With Neuro 3D task 
card from Syngo software, areas where functional information is superimposed upon anatomic data 
can be checked against the field map. If field map distortion and functional activation overlap, then 
this information must be ignored for the reason that local distortion and signal loss “contaminate” 
that region. Otherwise, FSL allows not only field map display over the anatomic structural image but 
also correction of the EPI distortions, although it can’t restore signal loss. In practice, this approach is 
very useful to allow a better registration and to achieve fewer errors in the spatial localisation of 
activations with functional data.  
 
5.2. Comparing three functional protocols 
 
With Neuro 3D, the statistical map (t-map) from BOLD protocol data was displayed over the 
structural anatomic image of each subject. Figure 5.6 illustrates the achieved image: we can see the 
activation clusters in the primary hand motor cortex of the left hemisphere, which is consistent with 
bibliography findings.  
 
 
 
 
Figure 5.6: BOLD statistical map obtained with FSL from Subject 2. BOLD results are displayed over the structural anatomic 
image. 
 12.7 
    
  4.8 
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The functional ASL data processing with Neuro 3D was limited. Therefore, it was only possible to 
analyse the ASL protocol #1, and not the ASL protocol #2, with this software. In that case, we have 
performed the subtraction between the quantitative relCBF map corresponding to the rest state and 
the quantitative relCBF map corresponding to motor activation (the procedure is presented in 
Appendix A A.1). The result of this image processing is shown in Figure 5.7. 
 
 
 
 
Figure 5.7: Perfusion maps obtained with Neuro 3D, for 16 axial slices in one subject. With this software, relCBF maps are 
co-registered to the structural space, and then the image processing was carried out. Top: quantitative relCBF maps 
corresponding to the rest state and to motor activation (respectively). Bottom: resultant map from the subtraction of the 
previous maps.  
 
As we can see, the difference image exhibits signal intensity in the primary sensory motor region, 
which reflects the perfusion change between the two states. Then, this difference image also shows 
the brain region that was activated by the motor task. For better comparison, we performed a fusion 
between BOLD information and the difference image (see Figure 5.8).  
 
𝑟𝑒𝑙 𝐶𝐵𝐹𝑟𝑒𝑠𝑡  
𝑟𝑒𝑙 𝐶𝐵𝐹𝑎𝑐𝑡𝑖𝑣𝑎𝑡𝑖𝑜𝑛  
𝑟𝑒𝑙 𝐶𝐵𝐹𝑎𝑐𝑡𝑖𝑣𝑎𝑡𝑖𝑜𝑛 −  𝑟𝑒𝑙 𝐶𝐵𝐹𝑟𝑒𝑠𝑡  
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Figure 5.8: Fusion between BOLD t statistical map and the ASL difference map between 𝑟𝑒𝑙𝐶𝐵𝐹𝑎𝑐𝑡𝑖𝑣𝑎𝑡𝑖𝑜𝑛  and  𝑟𝑒𝑙𝐶𝐵𝐹𝑟𝑒𝑠𝑡  
maps. Grey colour scale is related to CBF absolute units (ml/100g/min), and the hot metal colour scale corresponds to the t-
value from the t statistical test. 
 
In the fused image, we can see that there’s some agreement between both informations in the 
motor activation region, since there’s an overlap between BOLD statistical map and the difference 
image between relCBF maps. However, we are combining and comparing here two different types of 
information that can lead to an erroneous interpretation. In this approach, BOLD information is 
provided by a statistical t test that results from several complex steps, while ASL information is the 
result of a simple subtraction between two images acquired in different conditions. In fact, we 
performed a fusion of a statistical map with a CBF difference map, which is not the best approach if 
we want to compare the specificity of both activations. It might have some applications, but with this 
approach we are not completely using the potential of ASL for functional analysis.    
With FSL we were able to perform a more complete analysis of functional BOLD and ASL 
protocol’s data. The post-stats results from BOLD protocol and functional ASL protocols #1 and #2 
are shown in Figure 5.9. 
 
BOLD signal from BOLD protocol 
 
 
 
BOLD signal from ASL protocol #1 
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CBF activation from ASL protocol #1 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure 5.9: Activation Z maps superimposed on an example EPI image obtained for each experiment of each protocol from 
subject 2. 
 
The group of images shown above demonstrates the z-map of BOLD activation from BOLD 
protocol and the z-maps of BOLD and CBF activations from ASL protocols #1 and #2 for one subject. 
For better interpretation of these results and to allow a better localisation of the hand motor area, 
the statistical maps were registered to the structural anatomic image space (see Figure 5.10). 
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BOLD from BOLD protocol
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BOLD from ASL protocol #1 
 
 
L R 
 8.3 
   
 2.5 
11.4 
   
 2.5 
 7.6 
   
 2.5 
 7.6 
   
 2.5 
FUNCTIONAL BRAIN PERFUSION EVALUATION WITH ASL AT 3 TESLA  
50 
 
L R 
CBF activation from ASL protocol #1 
 
 
 
L R 
 
 
L R 
BOLD from ASL protocol #2 
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L R 
CBF activation from ASL protocol #2 
 
 
 
L R 
 
Figure 5.10: Activation Z maps (scale indicated in colorbar) obtained for each experiment of each protocol superimposed on 
the structural anatomic image from subject 2: from left to right we have the axial, sagittal and coronal planes, respectively.  
 
 7.6 
   
 2.5 
 8.3 
   
 2.5 
 8.3 
   
 2.5 
CHAPTER 5 – RESULTS AND DISCUSSION  
51 
For all subjects, the three functional protocols were able to give information of activation areas in 
the HMC of the left hemisphere of the brain. Although it wasn’t expected good results with ASL basic 
protocol #1 data, functional information can be seen in the statistical map obtained for CBF 
activation. However, ASL protocol #1 doesn’t have a design’s shape commonly used to assess 
functional information. It consists in a single block design which is not optimized for functional 
studies. In this protocol, distinctively from the others functional protocols, there is only one change 
between the condition of rest and the condition of activation. As we know, the measured functional 
signal is based on changes between the state that we want to explore and a state of reference. If 
there is only one exchange between these two states, the study will be limited to few relevant 
statistical data, which can induce poor functional information. According to that, we can conclude 
that ASL protocol #1 is not optimized for functional studies. In fact, the BOLD activation results 
extracted from ASL protocol #1 are not consistent with the results given by the other experiments, as 
we can see in Figure 5.10; they don’t point the activation region near the HMC on the left side of the 
brain.  
Therefore, the basic ASL protocol #1 was discarded for functional studies and changed to ASL 
protocol #2, which provided significantly better results. Indeed, for this new protocol both BOLD and 
perfusion activation regions are consistent with the expected, providing a good localisation of the 
brain region responsible for the motor task. 
Moreover, the optimized functional ASL protocol #2 allows simultaneous BOLD and perfusion data 
acquisition, since both contrasts can be retrieved from a single acquisition.  
 
5.3. Variability of extent and localisation of motor activation  
 
The MNI coordinates for the centre of gravity (COG) of the activation regions, as well as the 
number of activated voxels, for each subject and for each protocol, BOLD, BOLDASL and CBF, are 
summarized in Table 5.1. 
The mean number of activated voxels in the hand motor cortex was 27.0 ± 4.7 for CBF, 
299.7 ± 54.0 for BOLDASL and 386.1 ± 78.2 for BOLD, as summarized in Table 5.2. Analyses of 
Variance (ANOVA) revealed significant differences in the number of voxels between the three 
experiments (𝑝 < 0.050). Post-hoc multiple comparison of mean voxel values according to Scheffe 
revealed significantly fewer activated voxels for CBF relative to BOLDASL (𝑝 = 0.004) and for CBF 
relative to BOLD (𝑝 < 0.001). 
Table 5.2 summarises the results of the variance of each coordinates for each experiment across 
the 15 subjects. The variance values of the COG coordinates for CBF activation are smaller than the 
variance values for the other modalities.  
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Table 5.1 
Results for the analysis of the location of activation measured by the centre of gravity (COG) and number of activated voxels 
for BOLD, BOLDASL and CBF  
Subject MNI coordinates for centre of gravity  𝑥, 𝑦, 𝑧  in mm Number of activated voxels 
 BOLD BOLDASL CBF BOLD BOLDASL CBF 
1 -28.9 -12.8 42.3 -17.3 -20.4 67.9 -31.8 -28.9 53.3 265 110 33 
2 -19.3 -9.19 46 -39.9 -18.5 60.3 -36.7 -19.3 52.3 614 58 12 
3 -33.1 -18.0 47.2 -26.0 -40.7 59.2 -38.3 -22.1 51.4 773 258 29 
4 -40.5 -8.51 50.5 -36.6 -19.6 59.5 -35.4 -23.1 50.8 215 156 24 
5 -20.8 -5.4 50.1 -23.8 -20.1 55.2 -31.1 -19 52.8 176 125 10 
6 -14.7 -41.2 55.6 -42.9 -17.1 53.0 -35.3 -17.6 57.3 94 63 7 
7 -32.2 -27.5 51.9 -22.7 -6.15 56.6 -30 -22.9 56.2 193 380 33 
8 -33.2 -26.3 51.6 -34.6 -17.2 57.5 -38.4 -13.7 54.1 117 281 87 
9 -41.2 -3.94 49.6 -20.0 -7.85 42.5 -30.6 -17.4 48.8 299 765 20 
10 -36.4 -18.4 57.3 -20.7 -28.9 57.7 -35.3 -16.3 51.8 438 479 20 
11 -43.2 -31.4 49.3 -28.8 -12.6 53.4 -39.5 -12.2 52.0 1173 372 28 
12 -37.1 -15.1 52.8 -42.7 -15.7 61.9 -35.9 -10.3 53.5 693 472 18 
13 -41.8 -10.1 51.8 -39.8 -12.4 47.0 -38.2 -14.6 52.1 142 187 31 
14 -30.5 -10.6 57.8 -38.2 -36.1 53.2 -36.2 -12.2 53.2 305 603 31 
15 -31.8 -24.1 49.3 -31.6 -26.5 51.3 -32.7 -25 58.0 294 186 16 
             
G. mean -32.3 -17.5 50.9 -31.0 -20.0 55.8 -35.0 -18.3 53.2 386.1 299.7 27.0 
± (SE) (2.2) (2.7) (1.1) (2.3) (2.5) (1.6) (0.8) (1.4) (0.6) 78.2 54.0 4.7 
 
 
Table 5.2 
Results for the calculation of variance of MNI COGs for CBF, BOLDASL and BOLD activations across 𝑁 = 15 subjects  
Experiment N 
Range 
(mm) 
Minimum 
(mm) 
Maximum 
(mm) 
Std. Deviation 
(mm) 
Variance 
(mm
2
) 
CBF 
Activation 
X 15 9,5 -39,5 -30,0 3,0889 9,541 
Y 15 18,6 -28,9 -10,3 5,3181 28,282 
Z 15 9,2 48,8 58,0 2,4450 5,978 
BOLDASL 
activation 
X 15 25,6 -42,9 -17,3 8,8519 78,357 
Y 15 34,5 -40,7 -6,2 9,6208 92,561 
Z 15 25,4 42,5 67,9 6,1616 37,966 
BOLD 
Activation 
X 15 28,5 -43,2 -14,7 8,5477 73,063 
Y 15 37,3 -41,2 -3,9 10,3146 106,391 
Z 15 15,5 42,3 57,8 4,1043 16,845 
 
 
The variance across subjects can be qualitatively evaluated with the illustration in Figure 5.11. In 
this figure, the inter-subject activation maps obtained for the three protocols are shown on the MNI 
standard brain. These maps represent the COGs and the local maxima of the activation clusters for all 
subjects, for each experiment. Figure 5.12 shows that the activation cluster achieved with CBF is 
within both BOLD and BOLDASL activation clusters.  
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Figure 5.11: Orthogonal views (coronal, sagittal and axial) of inter-subject activation maps for BOLD (red), BOLDASL (green) 
and CBF (blue) in the MNI standard brain.  
 
 
Figure 5.12: 3D views of inter-subject activation clusters for BOLD (red), BOLDASL (green) and CBF (blue). On the left is 
represented the MNI brain, and on the right is represented the MNI brain without a piece of it to show activation clusters. 
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These results show that between-subject variability in motor activity localisation was smaller 
when measured with perfusion fMRI as compared with BOLD fMRI. On the other hand, the group 
activation maps showed larger areas of BOLD and BOLDASL activations compared to CBF (see Figure 
5.11 and Figure 5.12), reflecting the superior sensitivity of BOLD compared to ASL. Since perfusion 
images are not sensitive to many of the non physiologic factors that impact BOLD images, this is an 
expected result. These results suggest that blood flow changes were more consistent across subjects 
than changes in BOLD contrast.  
Figure 5.13 shows the positions of the 9 points used to localise the HMC of the left hemisphere of 
the MNI standard brain. The two mean points C1 and C2 are also displayed in this figure. 
 
 
Figure 5.13: Localisation of the hand primary motor cortex. The representation on the top left corner illustrates the 9 points 
over the segment of the precentral gyrus (red) and the two mean points calculated (blue). The same points are shown in 
the MNI brain axial slices (bottom). The segment of the precentral gyrus is not contained in one single axial slice, so we had 
to localise it over four different axial slices, positioned as illustrated on the top right.    
 
Figure 5.14 summarises the mean Euclidean distance from the 11 points of HMC to BOLD, BOLDASL 
and CBF activation COGs.  
ANOVA revealed significant differences in the distances between BOLD, BOLDASL, and CBF COGs 
with respect to CL (𝑝 < 0.017), L1 (𝑝 < 0.019), C1 (𝑝 < 0.017) and C2 (𝑝 < 0.009). The post-hoc 
multi comparison of the mean distance values according to Scheffe revealed significant differences 
between the following distances: CBF and BOLDASL COG to CL (𝑝 < 0.036), CBF and BOLDASL COG to 
L1 (𝑝 < 0.027), CBF and BOLD COG to C1 (𝑝 < 0.041), CBF and BOLDASL COG to C1 (𝑝 < 0.046), CBF 
and BOLD COG to C2 (𝑝 < 0.010) and CBF and BOLDASL COG to C2 (𝑝 < 0.013). A quantitative 
exposition of Figure 5.14 is given in Appendix A A.4, with the distance values for each subject.  
The localisation of the HMC allows the comparison of the spatial location of activation COGs in 
the MNI standard brain. We found that CBF activation was closer to the HMC points compared to 
BOLD and BOLDASL. This supports the notion that CBF may more accurately localise brain activation 
due to its greater sensitivity to changes in the capillary bed local to the activated neuronal population  
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Figure 5.14: A plot of the group mean Euclidean distance (in mm) from HMC points to CBF, BOLDASL and BOLD activation 
COGs. Error bars denote one standard error of the group mean. * denotes significant differences between the pointed bars. 
 
than the venule side – as is the case for BOLD contrast. Indeed, some BOLD fMRI studies showed 
apparent activation over distant draining veins that is not observed using perfusion contrast (see 
Figure 5.15). 
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BOLD Activation 
 
Figure 5.15: Representation of BOLD and CBF activations in coronal slices of subject 12 (presented from anterior to 
posterior, from left to right and from top to bottom in the figure), showing apparent activation over draining veins for BOLD 
experiment, but not for ASL. 
 
In Figure 5.15, activation detected with perfusion MRI is confined to the HMC, whereas BOLD 
contrast also shows apparent activation over the superior longitudinal sinus (indicated by arrows) 
which drains motor cortex. Furthermore, considering the original points drawn to localise HMC, as 
we can see in the graph of Figure 5.14, CBF was significantly closer to the central and lateral points CL 
and L1, and mean points C1 and C2, which is consistent with a study that showed individual digit 
activated areas with predominance in the lateral region of the segment of the precentral gyrus [51]. 
Despite all of this, we have to be careful when we are looking for the evidence for greater 
accuracy of localisation with CBF. If we consider the group mean Euclidean distance between the 
modalities (see Table 5.3), we observe that these values are within the intrinsic spatial resolution of 
collected data (3.5 × 3.5 × 6 mm3 for CBF and BOLDASL and 4 × 4 × 3 mm
3 for BOLD). 
 
Table 5.3 
Group mean Euclidean distance between modalities (BOLD, BOLDASL and CBF) 
 Euclidean distance between 
BOLD and BOLDASL 
Euclidean distance between 
CBF and BOLDASL 
Euclidean distance 
between CBF and BOLD 
          
Group mean  
± SE 
5.65 ±  1.05 𝑚𝑚 5.06 ±  1.10 𝑚𝑚 3.64 ±  0.93 𝑚𝑚 
 
Although the MNI standard space to which the experiments were registered has a better 
resolution (2 × 2 × 2 mm3), the space where functional data was collected is the one that we must 
consider. In fact, these differences could be due, at least in part, to registration problems during 
“draining vein” 
CHAPTER 5 – RESULTS AND DISCUSSION  
57 
transformation from functional to the structural space of the MNI brain. Moreover, we mustn’t 
forget that, for registration of ASL data, comparing with BOLD data registration, we needed to do an 
additional transformation (since the imaging slab doesn’t cover the whole brain), which consists in 
using a low resolution image that covers the entire brain (in practice, an EPI image from BOLD data). 
The usage of an additional transformation introduces one additional source of errors, which can 
affect the localisation of activation COGs in the structural space.   
Nevertheless, the consistency of the results is undeniable. In fact, 15 heads were analysed in this 
study, which provides a good statistical number for validation of the results. Besides, in literature 
there are some different approaches that support that this occurs [4, 42, 52-54]. So, and according to 
the information posted in Chapter 2 and Chapter 3 about the nature of BOLD and ASL signals, the 
results achieved corresponded to the expected. 
 
5.4. CBF quantification: comparing the three methods 
 
Figure 5.16 shows a typical quantitative perfusion-weighted image obtained from a 25 year-old 
female subject. 
 
 
 
    0 𝑚𝑙/100𝑔/𝑚𝑖𝑛    150 𝑚𝑙/100𝑔/𝑚𝑖𝑛 
 
Figure 5.16: A typical perfusion-weighted image from a 25 years old female subject. The first 8 axial slices are shown from 
inferior (top left) to superior (bottom right). The top slice (ninth slice) is not shown because it does not have any brain 
signal.     
 
For this study, only the image of rest from ASL protocol #1 was used. The values of perfusion used 
for comparison between the 3 methods described in Section 4.4.2, were obtained by applying the 
grey matter (GM) binary mask of each subject as a ROI.  
Table 5.4 shows the results of CBF values calculated by the 3 methods for each subject.  
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Table 5.4 
CBF values in 𝑚𝑙/100𝑔/𝑚𝑖𝑛 in the GM mask for each subject calculated using the three methods 
Subject Cerebral brain flow (CBF) values (± SE) in the grey matter mask in absolute units of 𝑚𝑙/100𝑔/𝑚𝑖𝑛 
 Method 1 Method 2 Method 3 
1 64.44  ±   1.23 66.46  ±   1.25 61.19  ±   1.28 
2 69.86  ±   1.80 71.88  ±   1.83 67.31  ±   1.89 
3 70.01  ±   1.34 72.06  ±   1.36 67.33  ±   1.44 
4 74.41  ±   1.45 76.87  ±   1.48 70.19  ±   1.51 
5 72.86  ±   1.79 75.79  ±   1.81 67.67  ±   1.87 
6 57.05  ±   1.28 58.92  ±   1.30 53.86  ±   1.35 
7 71.69  ±   1.52 73.97  ±   1.56 67.99  ±   1.53 
8 61.67  ±   0.98 63.83  ±   0.98 57.71  ±   1.06 
9 47.74  ±   1.17 49.43  ±   1.18 44.58  ±   1.22 
10 67.44  ±   1.11 69.88  ±   1.13 62.79  ±   1.17 
11 60.23  ±   1.00 62.34  ±   1.01 56.31  ±   1.08 
12 81.99  ±   1.07 85.08  ±   1.08 75.93  ±   1.19 
13 69.04  ±   1.35 71.86  ±   1.38 63.07  ±   1.38 
14 82.83  ±   1.26 85.89  ±   1.27 76.86  ±   1.36 
15 68.10  ±   1.17 71.08  ±   1.18 61.47  ±   1.24 
    
 
The graph of Figure 5.17 summarises the results given in Table 5.4, representing also the group 
average of CBF given by each method.  
 
Figure 5.17: A plot of perfusion values (in ml/100g/min) computed using the 3 methods for each subject and group mean. 
Error bars denote one standard error of the mean value. 
 
As we can see in the plot of Figure 5.17, the three methods used to perform quantitative maps, 
provided systematically different values for CBF. For all subjects, method 2 gave higher values of CBF 
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and method 3 gave lower values of CBF in grey matter. The 95% confidence intervals of CBF mean 
value is  62.95 ; 72.97   ml/100g/min  for method 1,  65.14 ; 75.57   ml/100g/min   for method 2 
and  58.96 ;  68.28   ml/100g/min   for method 3. Although there was an obvious trend, the 
differences in CBF values for the three methods were not significant. 
Considering these results, is not surprising that we found no significant differences between the 
values given by the three methods, which mean that the corrections of the CBF expression 
parameters didn’t represent great improvements on the perfusion values with respect to the original 
expression without any correction (method 1).  
 
5.4.1. Inter-slices effect 
 
The results shown in the previous section are global values in the grey matter mask across the 
whole volume. In light of the type of corrections that we made, it’s also important to evaluate the 
performance of these methods between the slices of the volumes. Considering the quantification 
methods used, CBF values between slices were evaluated in order to explore if there’re significant 
differences. For ASL data, 9 slices were acquired, but only the firsts 7 slices (from the bottom) have 
been considered in this analysis, since the top slices only had non-brain structures (see Figure 5.18).  
 
 
Figure 5.18: Illustration of the positions of the 9 axial slices acquired (images do not correspond to the respective positions).  
 
The group mean values for each slice determined using each of the three maps are shown in 
Figure 5.19.  
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Figure 5.19: A plot of perfusion values (in ml/100g/min) across the 15 subjects calculated with the 3 methods for the firsts 7 
slices. Error bars denote one standard error of the group mean. 
 
The plot of Figure 5.19 shows some differences between slices. For all methods, a decrease of CBF 
values across the slices can be observed. However, the tendency of the decrease of each method is 
different. The results of method 3 exhibit a more abrupt decrease across slices, while the decrease of 
the results of method 2 is more gradual.  
Comparing method 1 with method 2, the second method accounts for the acquisition time of the 
different slices. In fact, the slices of the volume are not acquired at the same time. Considering the 
ascending acquisition order of the EPI sequence used, top slices are acquired latter than bottom 
slices. This effect, if not accounted, can induce some errors in CBF quantification results between 
slices, providing an underestimation of CBF. As expected, the CBF values of method 2 are greater 
than the CBF values of method 1, especially for the top slices. Based on these results, we can say that 
method 2 provides a good correction for CBF estimation.  
Method 3 with respect to method 1 and method 2, not only accounts for the acquisition time of 
the slices, but also accounts for the correction factor 𝑞𝑝 , which includes the arterial transit time. 
However, as we can see in Figure 5.19, the decrease of CBF values between Slice 1 and Slice 7 is more 
pronounced if we use method 3. Indeed, the percentage of decrease of CBF with method 3 is 61.6%, 
while with method 1 it is 45.04% and with method 2 it is 40.5%. There are some reasons that 
explain why this happened. The most important one, however, seems to be the arterial transit time.  
As mentioned before, 𝑞𝑝  includes the transit delay of arterial blood. Since the tagged blood 
doesn’t reach all imaging slices at the same time, we had to estimate this parameter. For this, we 
have considered that the transit delay of blood per centimetre of distance travelled in the z axis 
is  500 msec. This relation for the transit time isn’t a very good assumption. Firstly, when we use this 
approach (considering a gap between the inversion slab and the imaging slab of  1.88 cm, and a slice 
spacing of approximately  1 cm), we are accepting that the time that arterial blood takes to reach the 
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top slice (Slice 7) is  3.94  sec. This is a very long time for tagged blood to reach brain structures. And 
secondly, we are considering a linear relation between the transit time and the distance that blood 
travelled in the z axis (see Figure 5.20a)). However, we know that this is not necessarily true: in fact, it 
may be a more realistic model that the transit time should be steadily shorter for the upper slices, as 
shown in Figure 5.20b).    
  
              
 
Figure 5.20: Relation between arterial blood transit time in arbitrary units (a. u.) and the distance travelled in z-axis (in a. 
u.): a) a linear relation that was used in the approach presented in this study, and b) a different and perhaps better 
approach for transit time estimation.  
 
Thus, this linear assumption seems to be a very rude approximation to what actually happens. The 
mode illustrated in the graph represented in Figure 5.20b) would probably be more appropriate.  
Nevertheless, the brain vascular system has a complex arrangement, which precludes any accurate 
estimation of this local parameter. These results highlight the importance of either determining 
transit time as part of the PASL measurement (which is possible with a multiple 𝑇𝐼 quantification), or 
knowing the approximate range of values that it is likely to take for a given application. 
This may be fully understood if we consider the simulation kinetic curves represented in Figure 
5.21, where the same parameters were used, except the arterial transit time variation (in this 
simulation we consider that the arterial transit time 𝛿𝑡 is 100 ms per cm of distance travelled in the 
z-axis). 
 
Figure 5.21: Theoretical curves of PASL signal versus time calculated from Equation 3.3. Slice acquisition effect considering a 
transit time variation of 100 msec per 1 cm in the z-axis. Grey vertical bar is readout time of the slices.    
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As it can be noticed from in Figure 5.21, the kinetic curve has not reached the descending part for 
all the slices at the time TI2 = 1.8 sec chosen for imaging or even considering the real time of slice 
acquisition. This can be confirmed by examining the mean curve across subjects for slice 6, for 
example (red line in Figure 5.21), where the acquisition time (1.8 sec plus correction for slice 
number) clearly falls on the rising portion of the curve. This means that this single TI method will 
consistently underestimate CBF if the assumption that the chosen 𝑇𝐼 is sufficient for acquiring the 
image in the descending portion of the curve is not met. In our data a consistent underestimation of 
CBF increasing with the slice number is observed, which can possibly be explained by the fact that 
the single 𝑇𝐼2 we chose, 1.8 sec, is not long enough and the effect observed in this simulation is 
affecting CBF quantification.  
This example evidences the importance of carefully choosing the acquisition time 𝑇𝐼2 when 
designing single 𝑇𝐼 ASL experiments. Acquiring the images at a conservatively long 𝑇𝐼2 has the 
disadvantage of decreasing SNR due to the decay of the control-tag difference signal. These data 
show that for this tagging geometry used, a 𝑇𝐼2 of 1.8 s is sufficient for the firsts 3 – 4 slices. In higher 
slices, with longer arrival times (longer transit times), the proportion of the slice where the 𝑇𝐼2 is too 
short is likely to increase. 
In conclusion, taking into consideration the above mentioned facts, we can say that method 2 
provides a better estimation of CBF than the other 2 approaches used. Moreover, by using this 
method we do not need to estimate intrinsic or local parameters neither to do approximations to 
calculate perfusion values. In fact, as demonstrated here, those assumptions could lead to an even 
more erroneous estimation of CBF. Therefore, method 2 seems to be the most accurate of these 
three methods, for single 𝑇𝐼 quantification with this sequence. Nevertheless, we must take into 
account the differences between slices, specially the higher slices, where we could be 
underestimating CBF. This problem, as mentioned before, could be solved with a multiple 𝑇𝐼 
quantification method, which provides not only CBF but also the arterial transit time.  
 
5.5. CBF quantification in Rest and Activation conditions 
 
The data sets used for this analysis were the time-series from ASL protocols #1 and #2, in order to 
evaluate the feasibility of both protocols for quantifying CBF variations between the conditions of 
rest and activation. The method used to obtain perfusion quantitative maps was method 2, since it 
was the one which gave best results. 
 
5.5.1. Comparing ASL protocols 
 
Table 5.5 shows the CBF values calculated with both protocols for the conditions of rest and 
activation and the difference between CBF of activation and CBF of rest (∆𝐶𝐵𝐹 = 𝐶𝐵𝐹𝑎𝑐𝑡 −
𝐶𝐵𝐹𝑟𝑒𝑠𝑡 ) in absolute unities (𝑚𝑙/100𝑔/𝑚𝑖𝑛) for the 15 subjects. 
The perfusion values presented in Table 5.5 were calculated applying the CBF activation clusters 
given by statistical analysis as a mask in the respective quantitative maps. It’s also important to 
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report one more time that both protocols were conducted in each subject at the same imaging 
session. 
 
Table 5.5 
CBF values provided by each protocol for both conditions of rest and activation for the 15 subjects 
Subject CBF values (ml/100g/min) calculated with ASL 
protocol #1  
CBF values (ml/100g/min) calculated with ASL 
protocol #2 
 𝐶𝐵𝐹𝑟𝑒𝑠𝑡  𝐶𝐵𝐹𝑎𝑐𝑡  ∆𝐶𝐵𝐹 𝐶𝐵𝐹𝑟𝑒𝑠𝑡  𝐶𝐵𝐹𝑎𝑐𝑡  ∆𝐶𝐵𝐹 
1 63.4 ± 6.9 121.3 ± 9.7 57.9 ± 5.4 84.4 ± 15.7 135.8 ± 16.6 51.5 ± 2.9 
2 79.6 ± 16.4 101.9 ± 17.6 22.3 ± 2.4 90.7 ± 10.5 115.2 ± 10.3 24.6 ± 2.1 
3 75.6 ± 10.7 103.8 ± 11.7 28.2 ± 2.1 84.8 ± 16.0 129.2 ± 24.1 44.5 ± 8.1 
4 71.9 ± 8.3 125.4 ± 8.4 53.5 ± 4.2 89.0 ± 12.5 117.1 ± 22.8 28.2 ± 10.3 
5 61.3 ± 7.1 119.2 ± 11.6 57.9 ± 5.5 71.2 ± 10.7 123.2 ± 17.1 52.0 ± 11.2 
6 45.1 ± 2.7 76.2 ± 4.9 31.1 ± 4.4 43.6 ± 7.7 84.1 ± 24.1 40.6 ± 6.4 
7 64.0 ± 11.4 85.4 ± 9.1 21.4 ± 4.2 79.5 ± 8.9 90.4 ± 9.3 10.9 ± 1.4 
8 57.0 ± 7.8 101.1 ± 10.1 44.1 ± 3.2 59.7 ± 5.6 94.1 ± 5.9 34.4 ± 3.3 
9 53.0 ± 10.1 101.9 ± 11.3 48.9 ± 2.3 56.4 ± 10.0 108.3 ± 11.4 51.9 ± 4.4 
10 53.7 ± 5.2 104.3 ± 6.6 50.6 ± 2.6 81.2 ± 10.9 106.3 ± 13.8 25.2 ± 2.9 
11 58.5 ± 4.6 104.8 ± 6.5 46.3 ± 3.6 56.3 ± 8.1 107.3 ± 10.3 51.0 ± 6.2 
12 56.2 ± 4.9 107.3 ± 7.7 51.1 ± 5.4 63.9 ± 10.8 115.4 ± 14.6 51.5 ± 4.8 
13 56.7 ± 6.1 111.9 ± 8.9 55.2 ± 5.5 76.2 ± 13.2 117.0 ± 7.5 55.1 ± 3.1 
14 73.8 ± 7.3 121.2 ± 7.6 47.4 ± 2.7 66.8 ± 13.2 122.5 ± 25.2 55.7 ± 12.1 
15 45.9 ± 6.3 86.0 ± 7.1 40.1 ± 2.5 52.2 ± 16.7 82.3 ± 13.8 30.1 ± 4.0 
       
Mean 
61.0 (± 2.7) 104.8 (± 3.7) 43.7 (± 3.2) 69.4 (± 3.8) 109.9 (± 4.2) 40.5 (± 3.6) 
(± SE) 
 
Figure 5.22 summarises the percentage of CBF change (%∆𝐶𝐵𝐹 = 100 × (𝐶𝐵𝐹𝑎𝑐𝑡 −
𝐶𝐵𝐹𝑟𝑒𝑠𝑡 )/𝐶𝐵𝐹𝑟𝑒𝑠𝑡 ) obtained with both protocols for the 15 subjects. 
 
 
Figure 5.22: A plot of perfusion change (%) between the conditions of rest and activation. Error bars denote one standard 
deviation. 
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As we can see, motor stimulation elicited marked CBF increases in the hand motor cortex, which 
ranged from approximately 20% to 100% for both protocols. Indeed, in the graph of Figure 5.22, 
considering only the values provided by the first protocol, we can see that, the increase of CBF for 
Subject 2 is only 27%, while the increase of CBF for Subject 13 is 97%. There are a few reasons that 
explain this variability between subjects and also between protocols. According with a study carried 
out by A. Kastrup et al. [55], one of the most important factors that affect CBF increases during 
activation is the stimulation frequency. CBF was calculated during a graded motor stimulation 
(bilateral finger tapping at different rates), and they found that CBF increases ranged from 32 ± 3 % 
(at a rate of 0.5 Hz) to 97 ± 8 % (at a rate of 3 Hz). There are some other studies that showed that 
different stimulation frequencies can indeed affect CBF increases during activation [16]. In this study 
the stimulation frequency was not controlled, so we cannot say who performed the motor task at a 
higher rate.  
 
 
    0 𝑚𝑙/100𝑔/𝑚𝑖𝑛    150 𝑚𝑙/100𝑔/𝑚𝑖𝑛 
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Figure 5.23: Quantitative perfusion maps (8 axial slices) provided by ASL protocols from subject 9. Firstly, the perfusion map 
from ASL protocol #1 and the corresponding structural image for reference (on top) are presented. Secondly, the perfusion 
map from ASL protocol #2 (on bottom) and also the corresponding structural image for reference are presented. Although 
the imaging sections are not the same for both protocols, due to the reduction of slice thickness from ASL protocol #1 to 
ASL protocol #2, the imaging slab covers the hand motor cortex in both cases. 
 
Therefore it is likely that some differences observed in CBF increases between subjects might be 
induced by this factor, since each subject could have performed the motor task at a different rate 
from the others. 
On the other hand, as we can see in Figure 5.22, the group mean CBF changes between both 
conditions were 73 ± 6 % for ASL protocol #1 and 62 ± 7 % for ASL protocol #2. We found no 
significant difference between the group mean values provided by both protocols, although the 
mean value given by the second protocol was 10% lower. These results showed that both protocols 
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were capable to detect variations in CBF according to the stimulus, and the results from the first and 
the second protocol were consistent. However, we must attend to the inferior SNR of the data while 
considering ASL protocol #2 to quantify CBF changes. In fact, Figure 5.23 shows the quantitative 
perfusion-weighted images provided by each protocol from a 27 year-old male subject. As we can 
see, the image provided by the second protocol is noisier and has a worse quality than the image 
provided by the first protocol. The SNR issues of these two images are discussed in the next section.   
 
5.5.2. SNR of perfusion-weighted images 
 
Figure 5.24 shows the group mean SNR of perfusion-weighted images provided by ASL protocol #1 
and ASL protocol #2. 
 
 
Figure 5.24: A plot of the group mean SNR of grey matter (GM) and white matter (WM) calculated for both protocols. Error 
bars denote one standard error of the mean.  
 
As expected, the mean grey matter perfusion SNR (31.2) calculated for ASL protocol #1 images 
was found to be significantly higher (𝑝 < 0.01) than the corresponding grey matter perfusion SNR 
(14.7) obtained for ASL protocol #2 images. For the white matter perfusion-weighted images from 
ASL protocol #1, the mean perfusion SNR (2.1) was also significantly higher (𝑝 < 0.01) than the 
corresponding mean value (1.0) from ASL protocol #2 images. These differences can be easily 
explained. We know that SNR increases in proportion to voxel volume (𝑣𝑜𝑥) and to the square root 
of the number of acquisitions (𝑁𝑎𝑞 ): 
 
𝑆𝑁𝑅 ∝  𝑣𝑜𝑥 × 𝑁𝑎𝑞  
 
Protocol #1 
Protocol #2 
 GM                  WM                                                                              GM                 WM  
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In fact, if we average several measurements of the signal, SNR will increase because we are in 
presence of white noise and its random contributions will tend to cancel out. That is what happens in 
this case. In fact, the voxel volume from ASL protocol #1 (128 mm3) is larger than the voxel volume 
from ASL protocol #2 (73.5 mm3), which means that SNR from ASL protocol #2 images should be 
lower. In addition, the number of measurements averaged to perform the quantitative perfusion 
maps from ASL protocol #1 was higher, 90, than the number of volumes used to obtain the 
quantitative perfusion maps from ASL protocol #2, 50 (see Figure 5.25). According to the SNR 
equation, an improvement of 1.55 in the SNR from protocol #2 to protocol #1 is expected. The ratio 
of the measured SNR values in grey matter, between protocols #1 and #2, is actually 2.12. The 
greater than expected difference in the SNR could be due to the alternation between rest and 
activation periods in protocol #2, which may have introduced additional sources of variances in the 
signal, as will be further discussed next. 
 
Figure 5.25: A schematic diagram for the assessment of the perfusion maps of each functional protocol. Perfusion maps 
from ASL protocol #1 were obtained by the average of 90 measurements, while perfusion maps from ASL protocol #2 were 
achieved by the average of 50 measurements. 
 
Therefore, although both ASL protocols allow the detection of perfusion signal change, the second 
protocol gives perfusion images with a lower SNR, which means that the background noise can 
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obtrude the desired signal with more impact and induce some errors in CBF quantification. So, it can 
be in the origin of the differences observed between the perfusion changes (%) given by both 
protocols. This factor can also be seen as a criterion for image quality, and is able to justify the worse 
quality of the images provided by ASL protocol #2 (see Figure 5.23). On the other hand, ASL protocol 
#2 provides images with better spatial resolution (thinner slices). 
As a final point, there is one other important vindication that could explain why the mean 
%∆𝐶𝐵𝐹 from ASL protocol #2 was lower than the corresponding mean value from ASL protocol #1. 
To perform the quantitative perfusion maps from the second protocol we had to concatenate the 
images from the rest blocks and the images from the activation blocks. However, the nature of the 
block design of this time-series (in this case, 5 blocks on and 5 blocks off) precludes any accurate 
division, i.e., in some cases the rest blocks or the activation blocks could have 11 or 12 volumes 
instead of the exactly 10 measurements considered. This would result in a lower mean signal change, 
which was what really happened. To avoid this we could select only fewer images from the middle of 
each block to concatenate, but this would result in a worse SNR of the resultant perfusion-weighted 
images. With ASL protocol #1 we don’t have this problem because we acquired one single series of 
images in rest, and one single series of images in activation, so the images were already divided. 
In conclusion, ASL protocols #1 and #2 were able to detect CBF changes between rest and 
activation conditions which ranged from 20 % to  98 %. The differences between both protocols 
consist in some aspects that have to be considered in the optimization of this functional protocol. 
Considering the SNR of perfusion-weighted images, it is important to define the number of 
volumes/repetitions acquired in each block, which impinges directly on the acquisition time (if we 
acquire more volumes, the acquisition time will rise), the slice thickness and the field of view, which 
directly affect the spatial resolution of the image (if we have larger voxel volumes, we’ll loss image’s 
spatial resolution). 
 
5.6. CBF quantification: effect of anterior and posterior circulation 
 
Figure 5.26 shows the position of ROIs 1 and 2 in each of the seven slices from a representative 
subject (Subject 3). 
 
 
Figure 5.26: Position of ROI 1 and ROI 2. Top images show the mean control-tag difference images of the firsts seven slices 
(from right to left, slice 1 to slice 7) from subject 3. Bottom images show ROI 1 (blue) and ROI 2 (red) for each slice. 
 
Figure 5.27 summarises the CBF values achieved to both ROIs in each slice using method 2. 
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Figure 5.27: A plot of the group mean CBF values (in ml/100g/min) for each slice. Error bars denote one standard error from 
the mean. 
 
The CBF values calculated for both ROIs in each slice were found to be close, i. e., there’s no 
significant difference between CBF values in ROI 1 and ROI 2. As we can see, the decrease of CBF 
values across the slices observed in early section 5.4.1 is observed here as well. However, we also see 
that, excepting slice 7, in all slices the CBF estimate values to ROI 1 are lower than the CBF values 
found to ROI 2. Indeed, the CBF estimate for ROI 2 is on average 9.8% (±2.2%) higher than for ROI 1.  
These differences can be explained by several aspects. The first one, and perhaps the most 
important, is the fact that the arrival times of blood to occipital and frontal regions could be 
different. Wong et al. [56] demonstrates that transit times vary across different regions of the brain, 
and Figueiredo et al. [5] have demonstrated maps of the tag arrival time. Namely, Gallichan et al. [57, 
58] found that the arrival times in the occipital region are longer than for the frontal region. The 
differences in the arrival time occur due to the brain vascular anatomy (anterior and posterior 
circulation).  
In the analysis presented in this study, where we used a single 𝑇𝐼2 quantification, we didn’t 
account for this factor, which is the same to say that we assumed a single transit time for both ROIs, 
which has been found to be not true. So, even if we consider just one slice for the analysis, the transit 
time seems to play an important role and can induce some errors in CBF quantification. In addition, 
previous works have indicated that the 𝑇1  of tissue is expected to vary across the brain, which 
introduces one more source of error. On the other hand, these small discrepancies may be partly 
explained by the various definitions of ROIs in the 15 subjects and also by differences in slice 
coverage. In literature, an atlas of predefined ROIs with the posterior and anterior circulation wasn’t 
found, so we had to draw by hand 30 ROIs for each of the seven slices.  
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In conclusion, CBF differences between ROI 1 and ROI 2 were found, mainly due to possible 
differences in the arterial transit time, or incorrect definitions of both ROIs. These facts suggest that 
it might be useful to build an atlas of normal values of both parameters for a range of ROIs 
predefined in standard space. Upon scanning a new subject, this would allow a quick determination 
of regions where the CBF or arrival times deviate from the normal range.     
    
5.7. CBF quantification in GM and WM 
 
A typical perfusion image from a 26-year-old female subject and the corresponding GM and WM 
binary masks obtained are shown in Figure 5.28. 
 
 
Figure 5.28: Representation of the grey matter (GM) and white matter (WM), automatically segmented, binary masks. Top 
images show the mean control-tag difference, perfusion-weighted images of the firsts seven slices (from right to left, slice 1 
to slice 7) from subject 12. Bottom images show the GM (grey) and WM (white) masks. 
 
The increased perfusion in grey matter compared to white matter can be clearly seen in the 
images shown before. The mean perfusion estimate of the voxels in each segmented region was 
calculated for each subject using the binary GM and WM masks. Figure 5.29 shows these results.  
 
Figure 5.29: A plot of CBF values (ml/100g/min) in automatically segmented grey and white matter masks for each subject. 
CHAPTER 5 – RESULTS AND DISCUSSION  
71 
The mean WM perfusion (53.0 ± 8.1 ml 100 g−1 min−1 ) was found to be significantly lower 
(𝑝 < 0.05) than the mean GM perfusion (70.4 ± 9.4 ml 100 g−1 min−1).  However, although the 
mean grey matter perfusion values fall within the expected range, as measured by a variety of 
techniques, the mean white matter perfusion values were too large relative to the expected. In fact, 
for GM the average perfusion value across the 15 subjects was 70.4 ml 100 g−1 min−1 with a range 
of 49.4 − 85.9 ml 100 g−1 min−1, and for WM it was 53.0 ml 100 g−1 min−1 with a range 
39.3 − 62.9 ml 100 g−1 min−1. Additionally, the mean ratio of grey to white matter perfusion 
(𝐶𝐵𝐹𝐺𝑀/𝐶𝐵𝐹𝑊𝑀 ) achieved, which reflects how much the perfusion in GM is higher than the 
perfusion in WM, was 1.3, confirming the small difference between the perfusion in both tissues 
(17.3 ± 4.7 𝑚𝑙 100 𝑔−1 𝑚𝑖𝑛−1). According with literature [1], this ratio has been found to be in a 
range of 2.5 − 3.0.  
These results can be easily explained by partial volume and segmentation effects. There isn’t a 
fine and single segmentation algorithm that allows an accurate segmentation of the brain in the 
classes that we want. Although we have segmented the brain in only three classes (GM, WM and 
CSF), segmentation errors are inevitable. This segmentation procedure is even more problematic if 
applied in a low resolution image as are the images provided by ASL. Furthermore, it can bring on 
significant partial volume effects, which if not considered, can induce important errors in CBF 
quantification of both tissues type, especially with large voxel volumes. In this analysis we used the 
binary masks provided by FAST, which don’t account for this outcome. 
 
5.7.1. Partial volume effect correction 
 
The partial volume effect (PVE) is the effect wherein insufficient image resolution leads to a 
mixing of different tissue types within a voxel, i.e., each voxel of the images can represent more than 
one tissue type. To compensate for this effect, we tried to use the partial volume maps (see Figure 
5.30) from FAST and calculate the real grey and white matter perfusion (since there’s no CSF 
perfusion) using the following approach: 
   
 
 𝑓 𝐺𝑀𝑚𝑎𝑠𝑘 =  𝑝𝑣𝑒𝐺𝑀 𝐺𝑀𝑚𝑎𝑠𝑘 𝑓𝐺𝑀 +  𝑝𝑣𝑒𝑊𝑀 𝐺𝑀𝑚𝑎𝑠𝑘 𝑓𝑊𝑀
 𝑓 𝑊𝑀𝑚𝑎𝑠𝑘 =  𝑝𝑣𝑒𝐺𝑀 𝑊𝑀𝑚𝑎𝑠𝑘 𝑓𝐺𝑀 +  𝑝𝑣𝑒𝑊𝑀 𝑊𝑀𝑚𝑎𝑠𝑘 𝑓𝑊𝑀
                                                Equation 5.1        
 
where  𝑓 𝐺𝑀𝑚𝑎𝑠𝑘  and  𝑓 𝑊𝑀𝑚𝑎𝑠𝑘  are the mean values of CBF in GM and WM binary masks, and 
 𝑝𝑣𝑒𝐺𝑀 𝐺𝑀𝑚𝑎𝑠𝑘 ,  𝑝𝑣𝑒𝑊𝑀 𝐺𝑀𝑚𝑎𝑠𝑘 ,  𝑝𝑣𝑒𝐺𝑀 𝑊𝑀𝑚𝑎𝑠𝑘   𝑝𝑣𝑒𝑊𝑀 𝑊𝑀𝑚𝑎𝑠𝑘  are the mean values of the 
GM and WM 𝑝𝑣𝑒_𝑚𝑎𝑝𝑠 in GM and WM binary masks, and 𝑓𝐺𝑀  and 𝑓𝑊𝑀  are the CBF values of the 
GM and WM respectively. 
Solving Equation 5.1 in order to 𝑓𝐺𝑀  and 𝑓𝑊𝑀  we reached to the following expression: 
 
 
 
 𝑓𝑊𝑀 =
 𝑓 𝑊𝑀𝑚𝑎𝑠𝑘  𝑝𝑣𝑒𝐺𝑀  𝐺𝑀𝑚𝑎𝑠𝑘 − 𝑓 𝐺𝑀𝑚𝑎𝑠𝑘  𝑝𝑣𝑒𝐺𝑀  𝑊𝑀𝑚𝑎𝑠𝑘
 𝑝𝑣𝑒𝑊𝑀  𝑊𝑀𝑚𝑎𝑠𝑘  𝑝𝑣𝑒𝐺𝑀  𝐺𝑀𝑚𝑎𝑠𝑘 − 𝑝𝑣𝑒𝑊𝑀  𝐺𝑀𝑚𝑎𝑠𝑘  𝑝𝑣𝑒𝐺𝑀  𝑊𝑀𝑚𝑎𝑠𝑘
𝑓𝐺𝑀 =
 𝑓 𝐺𝑀𝑚𝑎𝑠𝑘 − 𝑝𝑣𝑒𝑊𝑀  𝐺𝑀𝑚𝑎𝑠𝑘 𝑓𝑊𝑀
 𝑝𝑣𝑒𝐺𝑀  𝐺𝑀𝑚𝑎𝑠𝑘
                                                       
         Equation 5.2 
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    0     1 
Figure 5.30: Representation of the grey matter (GM) and white matter (WM) partial volume maps. Top images show the 
anatomic images of the first 7 slices (from right to left, slice 1 to slice 7) from subject 12. Middle images show the 
corresponding GM partial volume map and bottom images show corresponding WM partial volume map. 
 
Equation 5.2 was then computed to calculate the new grey and white matter perfusion values. 
These results are shown in Figure 5.31. 
 
 
Figure 5.31: A plot of CBF values (in ml/100g/min) of grey and white matters for each subject with and without partial 
volume effects correction. 
 
Table 5.6 summarises the results presented in Figure 5.31. 
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Table 5.6 
Mean CBF values in 𝑚𝑙/100𝑔/𝑚𝑖𝑛 in GM and WM calculated with and without partial volume effects (PVE) correction 
 CBF values (ml/100g/min) calculated without 
PVE correction in 
CBF values (ml/100g/min) calculated with 
PVE correction in 
 Grey matter White matter Grey matter White matter 
Group 
mean  
70.4 53.0 70.8 34.7 ± 8.0 
±𝑆𝐷 9.4 8.1 11.3 8.0 
𝐶𝐵𝐹𝐺𝑀
𝐶𝐵𝐹𝑊𝑀
 1.3 ± 0.1 2.1 ± 0.5 
 
As we can see, the results show significant perfusion changes with this partial volume effect 
correction. White matter perfusion was found to decrease 34.5%, which is in agreement with the 
expected. Besides, the ratio of grey to white matter perfusion increases from 1.3 to 2.1, 
demonstrating a closer to expected difference between the mean perfusion values of both tissue 
types. However, this still is a small value if we compare it to the values found in other studies. If we 
look closer to the images represented in Figure 5.30, it’s reasonable to think that FAST segmentation 
performance performed differently across the 7 axial slices. Indeed, in the lower sections, the 
presence of deep grey matter structures limits an accurate segmentation: those structures are in fact 
often erroneously classified as white matter. One example of this imprecise procedure is considering 
the basal ganglia. On the other hand, top slices nearly don’t have brain structures, so the 
performance of segmentation isn’t too good. This will result in an overestimation of white matter 
perfusion. To confirm this observation the group mean ratios of grey to white matter perfusion were 
calculated for each slice. Figure 5.32 shows these results. 
 
 
Figure 5.32: A plot of the mean ratios of grey to white matter perfusion in each of 7 slices calculated with (right) and 
without (left) partial volume effects correction. 
 
As we can see in the right graph of Figure 5.32, the ratio of grey to white matter perfusion is quite 
different if we consider, for example, slice 1 or slice 5. For slice 5 the ratio value is closer to the 
expected range of values (2.5 − 3.0), which confirms our previous observation. Furthermore, the 
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graphs of Figure 5.32 also show the real differences between GM and WM perfusion with and 
without PVE correction. In summary, an accurate segmentation (in the middle slices) allows for 
partial volume effects to be corrected, yielding an expected grey to white matter perfusion ratio. 
However, where grey matter structures are classified as white matter (bottom slices), white matter 
perfusion is overestimated and therefore the grey to white matter perfusion ratio is underestimated. 
Despite this, it is interesting and reasonable to compare the SDs of the perfusion values, which 
represent the inter-subject spread in perfusion. Some studies [6, 59, 60] have reported higher SDs for 
GM than for WM perfusion, which supports the present finding that GM perfusion variation between 
individuals is large. Although the cause of this variation stills unknown, it could be linked to individual 
variation in neuronal density [61] or neuron number [62], which are found to have a similarly large 
inter-subject variability. Individual differences in excitability levels during the scanning could also 
account for some of the perfusion differences seen in this study. 
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Chapter 6  
Conclusions 
 
6.1. Discussion 
  
In general, the study presented in this thesis accomplishes its principal objectives: provides the 
firsts results of the commercially available ASL sequence from Siemens implemented in the Hospital 
da Luz; contains some good approaches for functional validation of ASL technique with BOLD 
contrast; and includes some important quantification lines for clinical support. This work also 
accounted for the analysis and optimisation of the functional ASL protocol, and the evaluation of its 
potential to provide quantitative values of CBF. From these analyses, a few conclusions may be 
taken.  
Firstly, ASL protocol #1 should not be used for functional studies. As mentioned in the previous 
chapter, this protocol precludes an accurate activation detection because it does not employ an 
efficient stimulation paradigm. In fact, with this protocol we acquired one series of images in a rest 
state, and after a while, we acquired another in an activation state. Thus, we are not actually 
measuring the CBF changes that result from the alternating states of rest and activation, but only a 
simple difference in CBF between one state and another, which might give an erroneous result for 
functional studies.  
And secondly, we have demonstrated that the optimised functional ASL protocol #2 can replicate 
and produce better results for this kind of approaches, providing not only the CBF activation but also 
the BOLD contrast, which is an additional measure within the same setup. For clinical applications 
this functional protocol might be useful because it combines the better spatial specificity of ASL fMRI 
with the higher detection sensitivity of BOLD fMRI, and grants CBF quantification results of both 
baseline and activation states, which were found to be consistent with literature and previous results 
(with the initial functional protocol). Besides, the reduction of the acquisition time (by a factor close 
to 2) from the original protocol to this new one is another advantage that must be considered: it 
enables less motion artefacts and more comfort for the subject.  
Some of the different quantification approaches made in this work may be questioned. Yet, the 
results attained support the importance of considering some parameters on CBF quantification, 
namely the arterial transit time, and how they can influence the results if erroneous assumptions 
were made. Furthermore, our results revealed the importance of performing an accurate 
segmentation in order to achieve correction of partial volume effects. In fact, we showed that this 
can significantly influence grey matter and white matter perfusion values. Although some tissue 
classification errors are still present in the segmentation procedures used in the present study, the 
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slices where a correct classification was possible clearly show a substantial improvement in the 
accuracy of the perfusion measures obtained. It has therefore been illustrated that the partial 
volume effects should be accounted for in this kind of analysis. The approach used here seems to be 
a good correction method for these effects, since it provided more accurate results. 
Although the results in this work are very interesting, there were a number of factors that were 
not considered, and can be in the origin of some of the differences and discrepancies observed in this 
study. The original conditions of each subject before and during the respective imaging session could 
be different. For example, the imaging sessions weren’t all conducted in the same period of the day, 
neither in the same day of the week. Some studies have confirmed that these factors are able to 
affect brain perfusion values [6]. Even caffeine intake can affect CBF values. 
In conclusion, the main potentials and drawbacks of ASL perfusion imaging technique in brain 
activation studies have been demonstrated. Overall, in spite of some difficulties in arranging the 
fifteen imaging sessions due to the anticipated and common clinical schedule, the work was carried 
out as expected, and didn’t present any great problem that should be mentioned. 
 
6.2. Future prospects 
 
This first study provided some results for the clinical validation of functional ASL techniques. Yet, 
this validation for functional MRI should proceed by performing many other functional studies using 
different paradigms and different stimulations (visual, auditory, word generation, etc). Other tests 
with fMRI should be performed in order to analyse the reproducibility of ASL results. 
Also, CBF values calculated with the single 𝑇𝐼 quantification method used in this work should be 
compared to the CBF values obtained with the multiple 𝑇𝐼 quantification method, which provides the 
arterial transit time as well and can more accurately quantify CBF in different regions of the brain. 
One approach using this multiple 𝑇𝐼 method [63], has already been carried out in the end of this 
work. In addition, dynamic susceptibility contrast MRI could be used to cross-validate the perfusion 
values from ASL.  
One important clinical drawback of ASL is the fact that it does not provide CBV measurements. 
However, there is one technique called vascular space occupancy (VASO) that can be combined with 
ASL and provide simultaneously CBF and CBV [64]. 
Finally, as mentioned, some physiological factors potentially affecting perfusion values were not 
considered in this work. In future studies, a control for at least some of these factors should be 
made.   
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Appendix A  
Appendix 
 
A.1. BOLD-ASL fusion in Neuro3D 
 
The procedure to perform the fusion between the perfusion-weighted images from ASL and the 
statistical map given by BOLD in Neuro3D is described below.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Image Fusion 
 
      ASL + BOLD fMRI 
 
 
      Operation task cards used: 
 Neuro3D 
 3D 
 VIEWER 
 
 
 
 
 
Stage 1 
           Step 1 
 
 Begin with Neuro3D module. 
 Firstly, load MPRAGE series, which corresponds to 
the anatomic structural image. 
 Load EvaSeries_GLM, which corresponds to the 
functional image (activation map from BOLD). 
 
 
 
 
 
 
 
 
 
 The volumes loaded can always be seen in the folder 
Study. 
 In this case, three volumes have been loaded. 
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 The field map is loaded automatically with 
EvaSeries_GLM. 
 For a better optimisation of the relevant images 
visualisation, the field map should be disabled, or 
the Anatomy threshold (in Fieldmap Properties) 
should be adjusted. 
 
 
 
 
 
 
 
 
 Clicking in Functional Properties, the following 
window is displayed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 A number of parameters can be changed: 
 In Activation Color Palette, the colour of both 
positive and negative BOLD signals can be 
controlled, as the lower and upper thresholds of the 
t-value. 
 A smoothing can be applied in the images using the 
Interpolation tool. 
 In activation Map Filter the clustering size is chosen. 
20 is the default value. 
 In Anatomy Threshold the lower limit can be 
adjusted. 
 
 
 
 
 
 
           Step 2 
 
 Click in MPR Range. 
This tool allow the generation of parallel images in a 
predefined plane. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 In the properties window of this tool, the number of 
images, its thickness and the distance between two 
consecutive images can be chosen. 
 Click in the button 
The images are generated and appear in fourth 
window in the right inferior corner of the monitor.  
 Save the series of images by clicking on           and 
giving a name to it. 
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           Step 3 
 
 Preserving the previous definitions of MPR Range 
(same positions and same parameters), load relCBF 
which corresponds to the perfusion-weighted image 
from ASL. 
 The software will interpret this image as an 
activation map (i. e. as a functional image), so 
automatically the previous activation map is 
removed. 
 In Functional Properties a number of parameters 
can be altered (like Step 1).  
 In Activation Color Palette the colour of both 
positive and negative relCBF signals can be 
controlled, as the lower and upper thresholds of the 
t-value. In this case, the lower limit should be set to 
none. 
  The other parameters have already been discussed. 
 In MPR Range Properties, generate and save the 
new series of images. 
 
In this study, this step was performed for both 
relCBF maps corresponding to the condition of 
resting and to the condition of activation.  
 
Stage 2 
           Step 4 
 
 In VIEWER module, the series of images achieved 
can be visualised.  
 In this study, three series were generated: 
  
Original 
series 
EvaSeries_GLM relCBF relCBF 
Generated 
series 
BOLD 
(functional) 
ASL 
(rest) 
ASL 
(activation) 
 
 To convert the images to a conventional grey scale, 
begin for selecting the series.  
 Click in Save As, and save the series again with other 
name. 
 Then select the two same series and click in 
Evaluation  Dynamic Analysis  Arithmetic Mean. 
 After this procedure, a new equal series is 
generated, but in a grey scale. 
 This procedure was performed for the 3 series.     
           Step 5 
 
 To perform the image difference between CBF in 
activation and CBF in resting state begin for 
selecting the two perfusion ASL maps created. 
 Click in Evaluation  Dynamic Analysis  
Subtraction. 
 In the opened window, take into consideration the 
subtraction order (Act-Rep). 
 Click in Scalling, and set the minimum value to zero. 
 A new series corresponding to the subtraction of the 
previous series is created. 
 
 
 
 
 
 To perform the image fusion, the two relevant series 
created (the BOLD series and the subtraction image) 
to the MEDPC.    
 
Stage 3 
 
 In MEDPC load the BOLD series to the 3D module. 
 In the Patient list select the two series and click in 
Application  3D  Fused. 
 In Fusing Definition MPR, the properties of the fused 
images can be defined.   
 In this study the properties chosen were:    
 
 
 
 
 
 Create and save a new series of images with MPR 
Range, similar to step 2.    
 
ASL
BW Log (8 Bit)
C 387     W 939
BOLD
Hot Metal (16 Bit)
C 2307     W 567
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A.2. Quantification maps Shell Script routine 
 
The routine called Quantification_maps was performed in shell script Linux to make the 
quantification analysis simpler. It allows the construction of quantitative perfusion maps based on 
each of the three methods used in this study. The inputs needed for this script is the original time 
series of alternated control-tag images, the corresponding brain binary mask (that’s used to remove 
non-brain structures) and the grey matter binary mask to calculate M0. It allows also the change of 
the quantification parameters.  
In the box bellow, a small part of this Shell Script routine built to perform the perfusion 
quantification maps is represented.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
# Routine Quantification_maps # 
 
#!/bin/sh 
# ** Script Organisation 
# *** Perfusion maps performing from time series ASL   
# **** Perfusion quantification 
# ***** Inputs: time-series with alternated control-tag images 
 
# funciton Usage: how to use this script 
Usage(){ 
    echo "" 
    echo "Usage:    Quantification_maps <input_volume_4D>  <brain_epi_mask>   <GM_mask>" 
    echo "" 
    exit 1; 
} 
 
# function OUT: exit program 
OUT(){ 
    echo "" 
    echo "" 
    echo Done 
    echo "" 
    exit 1; 
} 
 
# function MENU: displays the list of options 
MENU(){ 
    echo "" 
    echo Choose your Mode:  
    echo "" 
    echo "************************************" 
    echo "*************** MENU ***************" 
    echo "************************************" 
    echo "* Mode[1] Mode [2] Mode[3] Exit[4] *" 
    echo "" 
    echo " [1]: Simple Wang expression without any correction  " 
    echo "" 
    echo " [2]: Wang expression with readout time correction  " 
    echo "" 
    echo " [3]: Buxton expression                          " 
    echo "" 
    echo " [4] Exit " 
    echo "" 
    echo "************************************" 
    echo "" 
}        
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# {{{ validation of input 
if [ $# -ne 1 ]; then 
    Usage; 
elif [ ! -e $1 -o ! -f $1 ]; then 
    echo "" 
    echo "File $1 does not exist or is not a regular file" 
    Usage; 
else  
    # {{{ get dimensions, i.e, get the values and put them on variables that are used below 
    filename=`remove_ext $1`; 
    nvols=`fslval $1 dim4`; 
    nslices=`fslval $1 dim3`;   
    # }}} 
fi 
# }}} 
 
# {{{ function signal diference: considering the 4D data, the first volume is deleted and then it's performed the  
        subraction of Control - Tag signals to obtain the mean signal (delta_M) 
    fslsplit $1;     # split 4D data  
    rm vol0000.nii.gz; 
    # performing the subtraction of Control - Tag singals  
    F=1; 
    while [ $F -lt $nvols ]; do 
 if [ $F -lt 10 ]; then 
     fslmaths vol000$F -mul -1 vol000$F -odt float; 
 else 
     fslmaths vol00$F -mul -1 vol00$F -odt float; 
 fi 
 F=`echo "$F+2" | bc`; 
    done 
    # Creation of new time series 
    fslmerge -t asl_new vol00*.nii.gz; 
    # Subtraction and Mean of time series 
    fslmaths asl_new -Tmean -mul 2 ${filename}_mean -odt float ; 
# }}} 
 
# {{{ acquire M0 value 
    fslmerge -t asl_control vol00*[02468].nii.gz 
    fslmaths asl_control -Tmean image_control -odt float; 
    fslmaths image_control.nii.gz -mas brain_epi_mask.nii.gz M_0_image -odt float 
    M0_image="M_0_image.nii.gz"; 
    fslmaths ${M0_image}.nii.gz -mas GM_mask.nii.gz M0_image_GM -odt float 
# }}} 
 
# {{{ remove all files which are useless 
    rm asl_control.nii.gz; 
    rm vol00*nii.gz; 
    rm asl_new.nii.gz; 
    rm image_control.nii.gz; 
# }}} 
 
# {{{ function Quantification: perform the perfusion quantification map (simple map) 
Mode="9"; 
until [ $Mode = "4" ]; do 
  MENU; 
  printf "Mode: " 
  read Mode; 
  if [ $Mode = "3" ]; then  
      echo Default values TI1 TI2 T1a lambda alfa 
      lambda=0.9; 
      echo lambda = $lambda ml/g 
      alfa=0.9; 
      echo a = `echo "$alfa*100" | bc` % 
      TI1=0.7; 
      echo TI1 = `echo "$TI1*1000" | bc` ms       
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      TI2=1.8; 
      echo TI2 = `echo "$TI2*1000" | bc` ms 
      T1a=1.5; 
      echo T1a = `echo "$T1a*1000" | bc` ms 
      T1=1.2; 
      echo T1 = `echo "$T1*1000" | bc` ms       
      deltat=0.5; 
      echo deltat = `echo "$deltat*1000" | bc` ms 
       
      n=0; 
      while [ $n = "0" ]; do 
   printf "Change parameters? <y/n> " 
   read resp 
   if [ $resp = "y" -o $resp = "n" ]; then 
       n=1; 
   fi 
      done 
 
      if [ $resp = "y" ]; then 
   printf "lambda= " 
   read lambda 
   echo $lambda | grep "[^.0-9]" 
   if [ $lambda='echo  "\n ###"' -o "$?" -eq "0" ]; then 
       lambda=0.9; 
   fi 
 
   printf "alfa= " 
   read alfa 
   echo "" 
   echo $alfa | grep "[^.0-9]" 
   if [ $alfa='echo "\n ###"' -o "$?" -eq "0" ]; then 
       alfa=0.9; 
   fi 
 
   printf "TI1= " 
   read TI1 
   echo "" 
   echo $TI1 | grep "[^.0-9]" 
   if [ $TI1='echo "\n ###"' -o "$?" -eq "0" ]; then 
       TI1=0.7; 
   fi 
 
   printf "TI2= " 
   read TI2 
   echo "" 
   echo $TI2 | grep "[^.0-9]" 
   if [ $TI2='echo "\n ###"' -o "$?" -eq "0" ]; then 
       TI2=1.8; 
   fi 
 
   printf "T1a= " 
   read T1a 
   echo "" 
   echo $T1a | grep "[^.0-9]" 
   if [ $T1a='echo "\n ###"' -o "$?" -eq "0" ]; then 
       T1a=1.5; 
   fi 
 
   printf "T1= " 
   read T1 
   echo "" 
   echo $T1 | grep "[^.0-9]" 
   if [ $T1='echo "\n ###"' -o "$?" -eq "0" ]; then 
       T1=1.2; 
   fi 
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                   printf "deltat= " 
   read deltat 
   echo "" 
   echo $deltat | grep "[^.0-9]" 
   if [ $deltat='echo "\n ###"' -o "$?" -eq "0" ]; then 
       deltat=0.5; 
   fi 
 
   echo New values 
   echo lambda = $lambda ml/g 
   echo a = $alfa "%" 
   echo TI1 = `echo "$TI1*1000" | bc` ms 
   echo TI2 = `echo "$TI2*1000" | bc` ms 
   echo T1a = `echo "$T1a*1000" | bc` ms 
   echo T1 = `echo "$T1*1000" | bc` ms 
   echo deltat = `echo "$deltat*1000" | bc` ms 
      fi 
 
      printf "Choose file for time correction: " 
      read file 
      echo "" 
      printf "Slice Spacing= " 
      read slice_spacing 
      echo "" 
      fslmaths ${filename}_mean.nii.gz -mas brain_epi_mask.nii.gz ${filename}_mean_masked -odt float       
      fslsplit ${filename}_mean_masked.nii.gz mean_calc -z 
      fslsplit M0_image_GM.nii.gz M0_slice -z     
      k=`echo "(1/$T1a)-(1/$T1)" | bc -l` ; 
 
      TI2_fixo=$TI2 ;  
      t=0; 
      time=0; 
      while [ $t -lt $nslices ] ; do 
   TI2=`echo "$TI2-($time/1000)" | bc -l` 
                    x=`echo "$t+1" | bc`; 
   time=`grep s_${x} $file | awk '{print $2}'`   
   TI2=`echo "$TI2_fixo+($time/1000)" | bc -l` 
   dt=`echo "$deltat*(1.88+($slice_spacing*$t))" | bc -l` 
   q=`echo "e($k*$TI2)*(e(-1*$k*$dt)-e(-1*$k*($TI1+$dt)))/($k*$TI1)" | bc -l` 
   echo "$q" >> q_values.txt     # save q values for a .txt file       
   M0_provis=`fslstats M0_slice000${t}.nii.gz -M` 
   fslmaths mean_calc000${t}.nii.gz -mul `echo "$lambda*e($TI2/$T1a)" | bc -l` -div `echo              
                                                                  "2*$M0_provis*$alfa*$TI1*$q" | bc -l` -mul 6000 CBF_M0slice_${t} -odt float ; 
 
                   t=`echo "$t+1" | bc` 
         
      done  
      fslmerge -z mapa3_${filename}_M0slice CBF_M0slice*.nii.gz ; 
      fslmaths mapa3_${filename}_M0slice.nii.gz -thr 0 mapa3_${filename}_M0slice -odt float 
      rm CBF_M0slice* ; 
      rm mean_calc00* ; 
      rm M0_slice* ; 
      echo Perfusion Maps created 
 
  elif [ $Mode = "2" ]; then 
      ... 
   elif [ $Mode = "1" ]; then 
      ... 
  fi 
done 
 
rm ${filename}_mean.nii.gz 
rm ${filename}_mean_masked.nii.gz 
 
OUT; 
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A.3. Functional images for all subjects 
 
BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.1: Functional images from Subject 1. 
 
 
BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.2: Functional images from Subject 3. 
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BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.3: Functional images from Subject 4. 
 
 
BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.4: Functional images from Subject 5. 
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BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.5: Functional images from Subject 6. 
 
 
BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.6: Functional images from Subject 7. 
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BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.7: Functional images from Subject 8. 
 
 
BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.8: Functional images from Subject 9. 
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BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.9: Functional images from Subject 10. 
 
 
BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.10: Functional images from Subject 11. 
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BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.11: Functional images from Subject 12. 
 
 
BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.12: Functional images from Subject 13. 
  
11.6 
   
 2.5 
10.8 
   
 2.5 
14.8 
   
 2.5 
13.3 
   
 2.0 
FUNCTIONAL BRAIN PERFUSION EVALUATION WITH ASL AT 3 TESLA  
94 
 
BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.13: Functional images from Subject 14. 
 
 
BOLD signal from BOLD protocol 
 
 
 
 
BOLD activation from ASL protocol #2 
 
 
 
CBF activation from ASL protocol #2 
 
Figure A.14: Functional images from Subject 15. 
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A.4. Distance to the hand motor cortex 
 
 
Table A.1 
Group mean Euclidean distance (in mm) from HMC points (M3, M2, M1, CM and CC) to CBF, BOLDASL and BOLD activation COGs for all subjects 
Su
b
je
ct
 
Mean Euclidean distance (mm) 
between M3 and the activation 
COGs given by 
Mean Euclidean distance (mm) 
between M2 and the activation 
COGs given by 
Mean Euclidean distance (mm) 
between M1 and the activation 
COGs given by 
Mean Euclidean distance (mm) 
between CM and the activation 
COGs given by 
Mean Euclidean distance (mm) 
between CC and the activation 
COGs given by 
CBF BOLDASL BOLD CBF BOLDASL BOLD CBF BOLDASL BOLD CBF BOLDASL BOLD CBF BOLDASL BOLD 
1 16.5 13,9 26.6 12.1 14.4 22.3 6.52 17.3 17.9 1.2 21.6 19.4 8.3 27.7 22.2 
2 24.0 26.6 24.2 19.2 22.5 21.3 12.7 17.0 19.8 10.0 13.9 24.1 9.5 11.4 29.1 
3 24.6 14.7 23.5 19.8 14.4 18.7 13.2 15.6 12.7 9.0 15.0 12.1 6.7 19.6 13.9 
4 21.8 23.1 33.4 17.0 18.9 28.8 10.3 13.5 23.0 6.8 11.0 21.5 7.4 10.6 19.8 
5 23.0 30.2 11.5 18.6 25.5 14.2 13.0 19.1 19.0 11.4 15.4 21.8 11.9 11.3 28.6 
6 15.8 24.8 17.5 11.2 22.0 12.9 5.5 20.2 6.7 5.9 23.8 2.2 11.4 28.0 8.1 
7 28.0 22.6 18.7 23.4 18.2 14.0 17.5 12.8 7.6 15.7 11.6 3.2 14.4 12.6 7.4 
8 21.4 27.3 37.2 16.6 24.2 32.7 11.1 22.3 27.1 11.9 26.1 26.1 15.1 30.6 24.5 
9 24.5 4.8 23.5 19.7 2.0 19.0 13.6 7.1 13.3 12.4 11.9 11.1 12.8 19.7 10.8 
10 30.1 22.1 28.6 25.4 17.9 24.4 19.4 13.7 18.6 17.6 15.7 12.6 15.9 19.1 6.6 
11 28.4 30.5 26.3 23.9 26.5 21.7 18.6 21.2 15.6 18.1 18.1 13.9 18.2 14.9 13.3 
12 27.7 31.6 33.2 22.9 26.8 28.5 16.8 20.6 22.5 14.9 18.8 20.5 13.7 17.1 18.1 
13 27.4 23.5 24.2 22.8 20.1 20.4 17.2 15.9 16.5 16.4 10.2 17.9 16.3 8.3 20.2 
14 17.4 17.3 19.0 13.2 12.6 14.1 7.9 6.2 7.7 5.0 3.1 6.1 8.8 8.9 10.2 
15 19.4 12.9 21.7 14.6 8.8 18.6 8.7 6.4 16.9 9.1 11.4 21.2 12.7 18.1 26.3 
Mean 
Group 
23.3
± 2.2 
21.7
± 3.8 
24.6
± 3.4 
18.7
± 2.3 
18.3
± 3.6 
20.8
± 3.0 
12.8
± 2.2 
15.3
± 2.8 
16.3
± 3.0 
11.0
± 2.5 
15.2
± 3.0 
15.6
± 3.1 
12.2
± 1.9 
17.2
± 3.7 
17.3
± 4.0 
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Table A.2 
Group mean Euclidean distance (in mm) from HMC points (CL, L1, L2, L3, C1 and C2) to CBF, BOLDASL and BOLD activation COGs for all subjects 
Su
b
je
ct
 
Mean Euclidean distance 
(mm) between CL and the 
activation COGs given by 
Mean Euclidean distance 
(mm) between L1 and the 
activation COGs given by 
Mean Euclidean distance 
(mm) between L2 and the 
activation COGs given by 
Mean Euclidean distance 
(mm) between L3 and the 
activation COGs given by 
Mean Euclidean distance (mm) 
between C1/C2 and the activation 
COGs given by 
CBF BOLDASL BOLD CBF BOLDASL BOLD CBF BOLDASL BOLD CBF BOLDASL BOLD CBF BOLDASL BOLD 
1 13.6 28.3 19.0 17.0 27.4 16.2 22.1 33.0 20.7 27.7 39.6 25.2 7.2/7.6 25.4/22.2 19.4/16.3 
2 5.6 6.8 26.4 6.5 7.7 22.7 11.9 10.9 28.0 17.9 17.0 33.3 6.4/3.9 9.5/8.5 26.0/21.8 
3 5.0 26.7 11.4 8.7 30.6 10.5 13.0 35.4 15.8 18.3 40.9 21.1 4.2/4.6 20.2/21.2 11.1/8.4 
4 8.0 7.7 12.1 10.7 8.6 6.5 15.7 13.3 7.4 21.2 19.6 11.7 4.7/3.8 8.1/5.9 17.4/15.2 
5 7.8 3.2 34.6 6.8 4.4 37.2 12.5 6.1 42.8 19.1 11.6 48.8 8.8/5.3 9.6/9.6 28.2/27.8 
6 12.5 23.9 12.5 13.6 19.2 15.7 19.5 24.2 20.9 25.8 29.9 26.4 8.6/5.2 24.6/20.0 6.5/6.6 
7 7.3 8.7 11.1 1.6 7.2 14.3 7.8 13.0 19.3 14.2 19.6 24.9 11.6/9.0 9.5/5.7 5.5/5.4 
8 12.8 27.6 16.7 11.3 23.9 11.0 17.1 28.7 10.4 22.9 33.4 12.6 12.0/8.4 27.6/23.7 22.1/19.8 
9 8.0 23.4 6.7 5.7 24.7 6.6 11.7 30.6 12.0 17.8 37.0 18.5 9.7/6.3 18.0/16.1 7.8/4.9 
10 8.4 15.1 12.4 2.7 11.3 18.3 6.8 17.2 20.2 12.7 23.4 23.3 13.4/11.1 15.7/11.2 9.3/13.6 
11 11.5 9.0 7.0 5.5 8.5 3.3 10.3 9.3 9.5 16.2 14.7 15.8 15.2/11.8 13.3/12.5 10.3/7.4 
12 6.9 10.6 10.1 2.7 7.2 4.8 8.4 9.4 5.1 14.5 13.4 10.2 10.9/8.5 14.8/13.1 15.9/14.0 
13 9.8 16.6 15.3 4.3 22.2 10.8 9.8 25.3 16.0 16.0 29.5 22.3 13.3/10.0 10.8/14.6 17.0/12.6 
14 11.3 12.6 12.0 13.8 15.3 13.8 19.0 20.6 19.2 25.2 26.2 24.8 6.6/5.1 7.0/6.4 7.9/6.3 
15 11.0 18.2 23.6 10.3 17.4 19.9 16.5 23.7 25.6 22.8 30.1 31.3 9.4/5.1 15.2/11.2 23.1/18.7 
Mean 
Group 
9.3
± 1.4 
15.9
± 4.3 
15.4
± 3.9 
8.1
± 2.4 
15.7
± 4.4 
14.1
± 4.3 
13.5
± 2.2 
20.0
± 4.8 
18.2
± 4.7 
19.5
± 2.3 
25.7
± 4.9 
23.3
± 5.0 
9.5±1.9/ 
7.1±1.1 
15.3±3.4/ 
13.5±3.1 
15.2±3.8/ 
13.3±3.5 
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AVALIAÇÃO DA ACTIVAÇÃO CEREBRAL 
NA FUNÇÃO MOTORA 
Em Ressonância Magnética pelas técnicas de Blood 
Oxygen Level Dependent e de Arterial Spin Labeling 
 
 
 
 
 
EVALUATION OF THE MOTOR BRAIN ACTIVATION BY MAGNETIC RESONANCE IMAGING 
USING BLOOD OXYGEN LEVEL DEPENDENT AND ARTERIAL SPIN-LABELING TECHNIQUES 
 
Marco PIMENTEL, Pedro VILELA, Inês SOUSA, Patrícia FIGUEIREDO 
M.P.: Faculdade de Ciências e Tecnologia. Universidade Nova de Lisboa. Lisboa 
P.V.: Departamento de Imagiologia. Neurorradiologia. Hospital da Luz. Lisboa 
I.S., P.F.: Instituto Superior Técnico. Universidade Técnica de Lisboa. Lisboa 
 
Introdução: A técnica BOLD (blood oxygen level dependent) é a mais usada e 
universalmente aceite nos estudos de ressonância magnética funcional. A técnica 
ASL (arterial spin labeling)é uma técnica não invasiva, de estudo da perfusão 
cerebral, que usa as moléculas de água como tracers endógeno de perfusão 
permitindo avaliar o fluxo sanguíneo cerebral (CBF). 
Objectivos: Avaliação comparativa da activação cerebral na função motora pelas 
técnicas BOLD e ASL. São apresentados os resultados iniciais desta análise 
comparativa. 
Metodologia: Num equipamento 3 Tesla (Siemens, Verio) foram avaliados 15 
voluntários por RM funcional, em tarefas de motoras da mão direita, usando as 
sequências BOLD (EPI) e ASL em repouso e em activação. O pós-processamento 
foi efectuado no software Neuro3D (Siemens). Foram analisadas a capacidade da 
técnica ASL em detectar alterações de fluxo entre o estado de repouso e da tarefa 
motora e a correlação topográfica entre as áreas de activação por ASL e BOLD. 
Resultados: Os resultados iniciais deste estudo comparativo demonstraram ser 
possível detectar as áreas de activação com a técnica ASL, e que estas áreas 
estavam em concordância topográfica com as obtidas pelo método BOLD. 
Conclusão: As conclusões iniciais sugerem que a técnica ASL pode ser usada no 
contexto da RM funcional; existindo algumas especificidades relativamente aos 
protocolos de aquisição e de pós-processamento que são discutidas. 
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ARTERIAL SPIN LABELLING FOR  
FUNCTIONAL MRI USING MOTOR TASK 
 
 
P. VILELA1, M. PIMENTEL2, I. SOUSA3, P. FIGUEIREDO3 
1HOSPITAL DA LUZ, LISBON, PORTUGAL,  
2FACULDADE DE CIÊNCIAS E TECNOLOGIA UNL, LISBON, PORTUGAL, 
3INSTITUTO SUPERIOR TÉCNICO UTL, LISBON, PORTUGAL 
 
 
Background and Purpose: The new clinically available arterial spin labelling (ASL) 
sequences present some advantages relatively to the blood oxygenation level 
dependent (BOLD) method for functional brain studies, namely the fact of being 
potentially quantitative and more reproducible. The aim of our study was to 
compare two functional clinical protocols, using BOLD and ASL, in terms of the 
activation detected in a pre-determined region of interest (ROI).  
Materials and Methods: Both ASL and BOLD imaging were performed on a 
Siemens Verio 3.0 T scanner. Eight healthy adult volunteers performed a motor 
finger tapping task. The BOLD protocol used a block design consisting of 4 cycles 
alternating 30 seconds of task with 30 seconds of rest. The ASL protocol consisted 
on the acquisition of one image during rest and another during the task. Post-
processing was performed using Siemens Syngo MR and an anatomical ROI was 
identified by a neuro-radiologist. For the BOLD protocol, the General Linear Model 
(GLM) was used to produce t-statistics maps of activation. For the ASL protocol, 
the rest and activation perfusion images were subtracted to produce an activation 
map. The scales of the BOLD and ASL activation maps were both normalized to 1 
and evaluated in the pre-defined ROI. 
Results: The mean (and standard error) activation observed for the BOLD and ASL 
protocols in the ROI was, respectively: 0.956 (0.035) and 0.943 (0.044). No 
significant differences were observed between the between the activation 
information provided by each protocol.   
Conclusion: Our data suggest that the functional imaging protocol using ASL 
produces comparable results to a conventional BOLD protocol. 
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